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Chirality is one of the most important topics in contemporary organic
chemistry.[1-3] Chirality in molecules is best compared to one’s own hands; they
are exactly the same, but each other’s mirror image and are in no way
superimposable.
The same phenomenon can occur in (organic) molecules. If a molecule
possesses an asymmetric center, for instance a carbon atom with four different
substituents (see Figure 1), its mirror images are not superimposable and the
molecule is called a chiral molecule (from the Greek word χειρ -cheir- which
means hand)
Figure 1: Example of a chiral “molecule” containing an asymmetric carbon atom with
four different substituents, and of two (chiral) hands.
This results in an R (Rex = right) and an S (Sinister = left) form of the molecule.
The R and the S molecules are called each other’s enantiomers. The fact that
molecules can have different spacial arrangements was first recognized by both
LeBel[4] and Van ‘t Hoff[5] independently in 1874; the latter received the first
Nobel prize in chemistry in 1901.
The main difference between two enantiomers is that they rotate the plane of a
polarized light beam in opposite direction of each other. So one enantiomer
rotates the light clockwise (+) whereas the other rotates it counterclockwise (-).
Although the differences between two enantiomers are very limited, they are of
great importance.
Many of nature’s essential building blocks are chiral, enantiopure, molecules
including amino acids, sugars and nucleosides. Because amino acids are chiral,
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this means that also all proteins including enzymes are chiral. The most
important consequence of the fact that enzymes are chiral (and enantiopure) is
that they also can commonly bind to only one of the enantiomers of a substrate
molecule, if this is also a chiral molecule. This property has serious
consequences for the pharmaceutical industry.[6] Since it is often not known what
kind of action the other enantiomer will display in the body, the pharmaceutical
industry has to be very careful when selling a drug as a racemic mixture (i.e.
both enantiomers are present in equal amounts in the mixture).
An example of two enantiomers that have different functions in nature are the
two forms of ketamine (1.1) which are depicted in Figure 2. Where the S form is
an anesthetic which is often used by veterinarians, the R form is a hallucinogenic
compound.[7]
Figure 2: S and R ketamine. Two enantiomers of the same compound with completely
different functions.
Another example of enantiomers that have completely different functions is the
molecule thalidomide, also known as Softenon®.[6] This compound was
distributed as a mixture of enantiomers in the 1950s and provided to pregnant
women to relieve nausea and insomnia complaints. But whereas the (R)
enantiomer of the compound relieved the nausea and insomnia complaints it
turned out that the (S) enantiomer blocked normal growth and development of
their unborn children leading to a significant rise in births of malformed babies
with women who used the drug.
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Figure 3: The two enantiomers of Thalidomide (1.2) and Limonene (1.3).
Not only in physiological processes related to drug action the differences
between enantiomers can be seen but also, for example, the smell of two
enantiomers can be completely different.[8] A nice example in this case is
limonene (1.3, see Figure 3) of which the (R) form has a pine-like smell whereas
the (S) from smells of orange peels.
1.2 Synthesis of chiral molecules
Because the two enantiomers of a chiral compound can have such different
biological functions it is of crucial importance for (organic) chemists to develop
methods for the enantioselective synthesis of chiral molecules.
As displayed in Figure 4 there are, presently, 3 main strategies for the
preparation of an enantiomerically pure compound.[9]
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Figure 4: Synthesis options for chiral, non-racemic, compounds.
 The first is to use one of the compounds from nature’s ‘chiral pool’. This is
a collection of compounds, the members of which are easily isolated from
natural sources as a single enantiomer, such as amino acids, glucose and
lactic acid. A drawback of this method is that mostly only one of the two
enantiomers of the molecule is accessible this way since only one of the
enantiomers is present in this chiral pool.
 The second is the separation of a racemic mixture, which is called
resolution. This can be achieved in two ways; via kinetic resolution
involving a chemical or biochemical chiral reagent or catalyst, in which
one of the enantiomers will react away and the other remains in pure form.
The other way is via selective crystallization using a chiral resolving agent.
The problem with these methods is the fact that the maximum yield is 50%,
since only halve of the mixture is of the correct chirality. This problem can
be overcome by performing a so called dynamic kinetic resolution. In a
dynamic kinetic resolution the non reactive enantiomer is racemized during
the resolution making it possible for the reaction to go to full completion.
Asymmetric Synthesis
Asymmetric catalysis Diastereoselective
Chiral pool Resolution of a racemic mixture
Using an auxilliary






 The third method is asymmetric synthesis in which a prochiral compound
is transformed into an, enantiomerically enriched, chiral one. This can be
done in three different ways.
o The first is based on the use of a chiral auxiliary. This is a chiral group
that can be attached to a molecule thus creating two or more
asymmetric centers. When there is more than one stereogenic center in
a molecule, molecules are no longer enantiomers but they are called
diastereomers. Diastereomers, in contrast to enantiomers, can be
separated based on differences in physical properties. When the desired
diastereomer is in hand, the auxiliary can be cleaved off again and the
enantiomerically pure compound is obtained. A drawback of this
method is the introduction of extra steps in the synthetic route
compromising the overall yield.
o The second way of making an enantiomerically pure compound via
asymmetric synthesis is by using a diastereoselective synthesis. With
this method a previously introduced stereogenic center is used to
selectively create a second stereogenic center by for instance taking
advantage of the difference in steric hindrance of the two
diastereomeric transition states involved.
o The last method for making an enantiomerically pure compound
through synthesis is via asymmetric catalysis, in which a prochiral
compound is transformed into an enantiomerically pure, or at least
enriched, chiral compound with the help of a chiral catalyst. This
catalyst can be a homogeneous, a heterogeneous, an organic or a
biochemical one. In general the chiral catalyst has one or more
interactions with the pro-chiral substrate. As a result of these
interactions an environment is created in which one of the two chiral
products is preferentially accessible. The strong point of this method is
the fact that, usually, only a small amount of the catalyst is needed to
make the reaction work in a selective manner. A drawback of this
method is the fact that most catalysts are highly reaction specific and
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for every reaction type a screening of catalysts and conditions is
needed to find the optimal performing combinations.
Despite its drawbacks asymmetric catalysis is becoming more and more
important in the synthesis of chiral products in both academia as well as in
industry.[9-12]
1.3 Homogeneous Asymmetric Hydrogenation
One of the most elegant and most studied reactions in asymmetric catalysis is
asymmetric hydrogenation. Until the 1960s, attempts to get some
enantioselectivity in a hydrogenation reaction relied on the use of chiral
auxiliaries attached to the substrate or by using a heterogeneous catalyst attached
to a chiral surface.[13] From the 1960s onwards, however, numerous methods for
performing asymmetric hydrogenations on a wide range of substrates have been
developed.[14] In the following a short historical overview is presented on the









When in the 1960s the use of phosphorus ligands in transition metal catalyzed
reactions was discovered and the Wilkinson-catalyst (Figure 5) was
developed[15;16] it did not take long before the first chiral phosphorus ligands
were employed in a homogeneous hydrogenation reaction. In 1968 it were the
groups of Horner[17] and Knowles and Sabacky[18] who reported the first
asymmetric hydrogenations using a P-chiral monodentate ligand.
The Knowles group was able to reach optical purities up to an excellent 90% in
the rhodium catalyzed asymmetric hydrogenation of several α-acyl amino
acrylic acids using CAMP (see Figure 5). The complex [Rh(COD)((Rp)-
CAMP)2]BF4 was used in the asymmetric synthesis of the anti-Parkinson drug
L-DOPA and was the first candidate for use in an industrial process. However,
with the discovery of DIPAMP, by the group of Knowles, which was able to
induce an ee up to 95%,[19] the CAMP ligand was replaced and the industrial
process for making L-DOPA relied on the use of DIPAMP ever since.[20] In 1975
Kagan and co-workers[21;22] introduced chiral bisphosphorus ligands which no
longer were P-chiral but had a stereogenic center in the backbone connecting the
two phosphine groups.[23-25]
Figure 5: [Rh(I)(PPh3)3]Cl; Wilkinson’s catalyst, the P-chiral phosphine ligand CAMP
as used by Knowles and Sabacky and the DIPAMP ligand as developed by Horner.
Since those first reports, many groups have been involved in the search for new,
faster and more selective catalysts for the hydrogenation of C=C double bonds
and a lot of progress has been made since.[26]
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Many different phosphorus ligands have been developed and used in highly
enantioselective asymmetric C=C bond hydrogenation.[27] Until 2000, all
successfully employed ligands were bidentates, but in that year three groups
independently (re)discovered that also a monodentate ligand can lead to good
conversions and excellent ee’s (vide infra) (re)opening a whole new field in this
type of research.
Figure 6: Monodentate ligands as used in asymmetric hydrogenations by the groups of
Pringle[28], Reetz[29] and ours.[30]
These groups were the group of Pringle and Claver who used monodentate
phosphonites,[28] the group of Reetz who used phosphites[29] and our own group
introducing phosphoramidites.[30] All three groups reported the hydrogenation of
dehydroamino acids in high yields and excellent ee’s, using a rhodium catalyst
which contained two of their monodentate ligands per metal center.







Besides C=C double bonds, also other types of double bonds can be
hydrogenated in an asymmetric fashion. In 1975 the first homogeneous Ru and
Rh catalysts were discovered for the asymmetric hydrogenation of C=N double
bonds. Botteghi et al.[31] and Kagan et al.[32] both used diop (see Figure 7) as




Figure 7: The first ligands successfully used in the homogeneous asymmetric C=N
hydrogenation.
The first hydrogenation reaching acceptable ee’s (up to 72%) was performed by
Vastag et al.[33] in 1984, using a bdpp-Rh complex in the hydrogenation of
C=N-Alkyl type substrates. In 1989 a Rh catalyst was developed with which, in
1992, the first very high ee (92%) in this type of hydrogenation was obtained
using mono-sulfonated bdpp (bdppsulf).[34-36] In 1999 Blaser and co-workers
published the use of a ferrocenyl based bidentate ligand (1.4) in the iridium
catalyzed asymmetric hydrogenation towards the product (S)-Metolachlor,
which is used as a herbicide.[37] This process is currently one of the largest
industrial enantiomeric catalytic processes exceeding 104 tons per year.
Figure 8: (S)-Metolachlor and the ferrocenyl type ligand (1.4) used in the iridium
catalyzed asymmetric hydrogenation during its production.
In 2008 Mršić et al. showed for the first time the use of monodentate ligands in
the asymmetric hydrogenation of C=N double bonds applying phosphoramidite
ligands. They were able to reach full conversion and up to 89% ee in the
asymmetric hydrogenation of quinolines.[38] Later our group reported ee’s of up
to 99% in the iridium catalyzed asymmetric hydrogenation of N-aryl imines
using monodentate phosphoramidite ligands.[39]
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1.3.3 Asymmetric C=O hydrogenation
The first asymmetric C=O hydrogenation was reported in 1972 by Bonvicini et
al. who reported the Rh-catalyzed hydrogenation of acetophenone and 2-
butanone. They obtained the resulting alcohols in 8.6% and 1.9% optical yield,
respectively, using (R)-benzylmethylphenyl phosphine (see Figure 9) as their
chiral ligand.[40] Since this first report a lot of work has been done and is still
going on in this field.
Figure 9: The chiral ligand as used by Bonvicini et al. in the first asymmetric
hydrogenation of a ketone.[40]
The first rhodium catalyzed asymmetric hydrogenation which resulted in good
ee’s was reported in 1980 by Törös et al. Using diop as a ligand they were able
to hydrogenate a number of acetophenones with an ee of up to 84%.[41]
Two key developments in this field came from the group of Noyori. In 1987 they
reported the use of binap in the asymmetric hydrogenation of functionalized
ketones using ruthenium complex 1.5. They were able to hydrogenate a few β-
ketoesters with excellent stereoselectivity.[42] This results was further extended a
year later when they published excellent ee’s in the asymmetric hydrogenation
of a large number of functionalized ketones.[43]
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Figure 10: The two binap-based Noyori catalysts for functionalized (1.5) and non-
functionalized ketones (1.6).
The second breakthrough came 8 years later, in 1995, when the same group
reported a system which was able to hydrogenate, the till then very difficult
substrate class of, unfunctionalized acetophenones. To the Ru-complex they
reported in 1987 they added a chiral 1,2-diamine creating the highly active and
selective catalyst 1.6, after activation by a base.[44] A more complete overview of
these important developments, including the mechanisms involved using these
two types of complexes will be given in chapters 2 and 4 of this thesis.
Despite the fact that the initial reports on asymmetric ketone hydrogenation
involved the use of a rhodium based catalyst, nowadays ruthenium is usually the
metal of choice in the asymmetric hydrogenation of ketones. Besides these two
metals, however, also other transition metals are able to function as catalysts in
this type of transformation. In chapter 3 an overview will be given on the use of
iridium in the asymmetric ketone hydrogenation. Here a small inventory is made
on the lesser common metals used in these hydrogenations.
1.3.3.1 Cobalt
In 1985 it were Massonneau et al.[45] who reported the first asymmetric cobalt
catalyzed hydrogenation of ketones. Using several di-cobalt complexes of the
form Co2(CO)6(PR3)2, they were able to reduce acetophenone with a very low
optical yield of 1.6% and 2-methyl cyclohexanone with an optical yield of up to
5%. Since then some cobalt complexes have been used with success in the
transfer hydrogenation or hydrosilylation of ketones (vide infra) but until now




Iron, which takes its place in the periodic table just above ruthenium, is of great
interest as a metal in catalysts because of its natural abundance and low price.[46]
It took until 2007 before Casey and Guan reported the first efficient iron catalyst
for the hydrogenation of ketones.[47] They were able to hydrogenate selectively
several acetophenones as well as alkyl ketones and 1,2-diketone in good to
excellent conversions using catalyst 1.7, however since no chiral ligand was
used also no ee’s were found.
The first asymmetric, iron based, hydrogenation catalyst was reported a year
later by the group of Morris.[48] Using a chiral P-N-N-P ligand (see 1.8 in Figure
11) they were able to hydrogenate acetophenone in 40% conversion and up to
27% ee. The enantioselectivity is not yet very impressive but a good starting
point for further optimization.
Figure 11: The first efficient iron catalyst (1.7) as published by Casey et al.[47] and the
first iron catalyst (1.8) used for asymmetric hydrogenation of ketones as published by
Sui-Seng et al.[48]
1.3.3.3 Osmium
Like iron also in the same group as ruthenium but then straight under it is the
element osmium. Being in the same group as the best performing metal for
carbonyl hydrogenations makes osmium a prime candidate for being used in this
type of reactions. It has been stated it would be an even better candidate
compared to iron and ruthenium, because it would bind stronger to the substrate
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making the reaction proceed even faster compared to the other two metals.[49] A
major drawback of using osmium however is the fact that all compounds or
complexes containing it display very high levels of toxicity. Besides being very
toxic it is also very expensive which prevents it from being a serious alternative
for the much less toxic and cheaper ruthenium. Nevertheless it has been used as
the metal in several ketone hydrogenation catalysts.
In 2008 Baratta et al.[50] reported the use of a osmium CNN pincer complex (1.9)
which in combination with Josiphos (See Figure 12) was able to hydrogenate
several acetophenones up to 98% ee with a remarkably low catalyst loading
(0.005 mol% Os).
Figure 12: The osmium pincer Josiphos complex (1.9) and the
[OsX2(diphosphine)(diamine)] complex (1.10) as used by Baratta et al[50;51] in the Os-
catalyzed asymmetric hydrogenation of ketones.
The same group improved on their results two years later when they introduced a
[OsX2(diphosphine)(diamine)] (X = Cl or OCH2CF3) (1.10) instead of the pincer
complex 1.9.[51] By using this complex, which very closely resembles the
original ruthenium complex, they were able to hydrogenate a range of
acetophenones with ee’s varying between 87 and 99%.
1.3.3.4 Palladium
Despite its great performances as a metal in other transition metal catalyzed
asymmetric transformations, such as Heck reactions, Suzuki reactions, allylic
substitutions and olefinic hydrogenations, palladium has not often been used
successfully in ketone hydrogenations.[52] It took until 2005 before the first
report was made of a palladium catalyzed asymmetric hydrogenation of a ketone.
It were Wang et al.[53] who published the use of a Pd/bisphosphine complex in
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the hydrogenation of a few functionalized ketones. When using methyl-DuPhos
as a ligand in 2,2,2-trifluorethanol they were able to reach up to 92% ee in the
hydrogenation of α-phthalimide ketones (1.11 in Figure 13). They recently
improved their initial results by using C10-TunePhos and are now able to obtain

























up to 99 % ee
L* =
1.12
Figure 13: The palladium catalyzed asymmetric hydrogenation of ketones as reported
by Wang et al.[53;54]
The second report using a palladium catalyst in a ketone hydrogenation was
made by the group of Beletskaya in 2009.[55] They discussed the asymmetric
hydrogenation of α-keto phosphonates 1.13 using a similar system as reported
later by Wang et al.[54] They were able to obtain full conversion but only
moderate ee’s up to 55% when using MeO-BIPHEP as a chiral ligand.





In 2007 the group of Shimizu published the first enantioselective method in
which copper was used in the catalytic complex. When the chiral BDPP ligand
was added to the precursor [Cu(NO3)(P(3,5-xylyl)3)2], in the presence of
NaOtBu and 3-6 equivalents of P(3,5-xylyl)3, they were able to reach full








Up to 91 % ee
R R
Ar = 3,5-xylyl
Figure 15: The copper catalyzed hydrogenation of acetophenones as published by
Shimizu et al.[56]
1.4 Other ways of reducing ketones asymmetrically
Besides the asymmetric hydrogenation of ketones using dihydrogen, over the
years also other methods have been successfully developed for transforming a
ketone into an alcohol in an asymmetric fashion. Here an overview will be given
on the asymmetric transfer hydrogenation, borohydride reduction,
hydrosilylation and enzymatic reduction.
1.4.1 Transfer hydrogenations
One of the most important alternatives for direct hydrogenation using hydrogen
gas is transfer hydrogenation.[57-59] In transfer hydrogenations two hydrogen
atoms, from an external hydrogen donor, are transferred onto the substrate. This
process is catalyzed by a (transition) metal catalyst. The two main hydrogen
sources used in transfer hydrogenation (Figure 16) reaction are secondary
alcohols, such as iso-propanol (IPA), and formic acid and its salts. Often a
formic acid / triethylamine mixture (TEAF) is used. IPA has the benefit of being
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environmentally friendly, easy to handle and cheap. However, there are a few
drawbacks to this method. Since the reaction is reversible, the outcome of the
reaction is determined by the oxidation potential of the ketone alcohol couple. A
way to drive the reaction to full conversion is performing it under slightly
reduced pressure in order to evaporate the acetone while it is being formed.
Figure 16: a) IPA; b) TEAF; the two most popular hydrogen donors in transfer
hydrogenation reactions.
The azeotropic mixture of 5 : 2 formic acid and Et3N is most frequently used
when TEAF is the reducing agent in a transfer hydrogenation. It is easily formed
by distilling a HCOOH / Et3N mixture just prior to use. Because during the
transfer hydrogenation reaction CO2 is formed the equilibrium is shifted to the
side of the desired product. A drawback of using TEAF is that some of the
catalysts are not able to cope with the acidic conditions and decompose rapidly
or lose their catalytic activity completely. Secondly it has been shown by the
group of Xiao that the optimum pH for transfer hydrogenations lies above the
obtained pH if the azeotropic TEAF mixture is used.[60] The low pH of the
mixture also makes that the catalysts which have to be activated by base are
usually not applicable when using TEAF.
Transfer hydrogenations proceed in general with a transition metal catalyst
present in the solution. When the reaction is aluminium catalyzed and IPA is
used as the hydrogen donor the reaction is also known as the Meerwein-
Ponndorf-Verley reduction whereas the backward reaction, the oxidation of the
alcohol, is known as the Oppenauer oxidation.
To date the best and most general catalyst for the asymmetric transfer
hydrogenation of ketones is the one developed by the group of Noyori.[61] The
catalytic complex consists of a half-sandwich Ru-arene to which the mono-
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tosylated DPEN is complexed, as can be seen in structure 1.15. Most catalysts
for transfer hydrogenation are based on Rh or Ru but there are some Ir,[62] Sm[63]
and Fe[46] catalysts known that show good performance. However, their
performances cannot compare to those obtained with Rh or Ru based catalysts.
Figure 17: The best performing transfer hydrogenation catalyst 1.15 to date as
developed by the group of Noyori.[61]
The benchmark substrates for asymmetric transfer hydrogenation are the
acetophenone type ketones. A number of ligands have been reported that
perform very well to excellent in the transfer hydrogenation of
acetophenones.[57;64] For the asymmetric transfer hydrogenation, mainly amino
alcohol type ligands are used, but also monotosylated or monomethylated
diamines perform very well is this reaction. Phosphine ligands generally perform
less well as ligands in the asymmetric transfer hydrogenation, but there are a few
that still give good to excellent selectivities.[65]
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Figure 18: Some representative, well performing, ligands in the asymmetric transfer
hydrogenation.
Besides the benchmark substrate acetophenone, other substrate classes have also
been tested; some of them are depicted in Figure 19. Most substitutions in the
phenyl ring or at the α-position of acetophenones can be tolerated in the transfer
hydrogenations leading to excellent ee’s.[66;67]
The only really difficult substrate, the t-butyl phenyl ketone, still is reduced with
a good selectivity resulting in 85% ee. In the case of the methyl alkyl ketones,
which are commonly reduced with low ee’s (36-63%), it is actually the t-butyl
substrate which gives the best result reaching up to 99% ee.
What can also be concluded from the results shown in Figure 19 is the fact that
β-ketoester are reduced less selective and they need a phenyl group in order to
give good to excellent ee’s.[68]
An additional advantage of transfer hydrogenation are the good results obtained
when water is used as a solvent. The groups of Xiao,[64] Guo,[69] Wang[70] and
others[71] dedicated their research successfully to developing this greener way of
reducing ketones. Various, catalysts, mainly based on Rh, Ir and Ru, have been




Figure 19: Various substrates which were tested in asymmetric transfer hydrogenation.
1.4.2 Borohydride reduction
The classical way of reducing ketones is via a hydride reduction using NaBH4 or
LiAlH4 in which the hydrides attack the carbon of the carbonyl function. The
boron or aluminiumalkoxide complex subsequently hydrolyses upon aqueous or
acidic work up creating the alcohol product. However, simple as this
transformation is, it produces a lot of environmentally unfriendly waste, since
the metalhydrides have to be used stoichiometrically. Moreover, the metal
hydride salts are not always easy to handle and can produce very reactive
reaction mixtures. Despite these drawbacks, a number of groups have
successfully put effort in developing asymmetric boranes to use in an
asymmetric version of the borohydride reductions.[73] Since in these cases still a
stoichiometric amount of the chiral hydride reagent was needed other groups
tried to develop a chiral borane which could be used in a catalytic fashion, thus
circumventing the need for stoichiometric amounts of chiral reagents.[74]
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Figure 20: A few CBS-type boranes (1.16, 1.17, 1.18) that perform excellent in the
boron based catalytic asymmetric reduction of ketones and an example of a cobalt
complex (1.19) used in the borohydride reduction of ketones.
The first to succeed in developing such a system were Corey, Bakshi and
Shibata, after whom the reagent was named (CBS-reagent, (1.16) Figure
20).[75;76]
Figure 21: Mechanism for the boron hydride based catalytic asymmetric reduction of
ketones using the CBS-reagent
The mechanism[77] of the CBS reduction, which is depicted in Figure 21 is well
understood and starts with a molecule of BH3 coordinating to the Lewis-basic
nitrogen of the CBS-reagent (I), after which the ketone can coordinate to the
boron atom of the CBS catalyst (II). A hydride subsequently transfers from the
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BH3-group to the ketone (III-IV) after which the product is released from the
reagent as its alkoxyborane and another BH3-molecule complexes again to the
CBS-reagent (I). Upon aqueous or acidic work up the alcohol is formed.
Besides the use of boranes as catalysts, Yamada et al. developed cobalt
complexes which can act as a catalyst in the borohydride reduction of ketones.[78]
Some of these complexes are made using a tetradentate β-ketoiminato ligand
(1.19, Figure 20) synthesized from a 1,3-diketone or a β-ketoester together with
a chiral 1,2-diamine. When a cobalt complex is used as catalyst, regular NaBH4
can be used as a reductant leading to ee’s up to 97% for acetophenone type
substrates.
Another interesting development in this field came recently from the group of
Falck.[79] They combined the enantioselective borane reductions and
enantioselective organocatalysis creating a method in which ketones can be
reduced asymmetrically using a catecholborane in combination with a thiourea
(1.20). With this method ketones could be reduced with selectivities up to 79-
99% ee.
Figure 22: The thiourea, 1.20, used by the group of Falck in the organocatalyzed borane
reduction of acetophenones.[79]
1.4.3 Hydrosilylation
A second, indirect, way of reducing ketones in an asymmetric fashion is by
hydrosilylation. In this process a ketone is reacted first with a silylhydride to
obtain a silylether. This silylether is hydrolyzed upon acidic workup to provide
the enantioenriched alcohol. The major advantage of using hydrosilylation for
the reduction of ketones is the fact that some silanes used for this transformation
are relatively cheap and easy to handle. From an atom economic point of view it
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is, however, not a very good reaction. A lot of waste is produced just like in the
borohydride reductions.
Figure 23: General scheme of asymmetric hydrosilylation.
The first hydrosilylation of a ketone was reported in 1972 by Ojima et al.[80]
Using the classical Wilkinson catalyst they were able to hydrosilylate
cyclohexanone and acetophenone to full conversion. Shortly after that first
report, also the first asymmetric hydrosilylation was reported by Yamamoto et
al.[81] They used a platinum catalyst containing the P-chiral phosphine
benzylmethylphenyl phosphine obtaining up to 18.6% optical yield in the
reduction of t-butylphenyl ketone. Since these first reports many Ir, Rh and Ru
based catalysts have been developed that give high stereoselectivity.[62;82] But
also the, in the classical asymmetric hydrogenation less common, metals like
Cu,[83;84] Co[85] and Fe[85;86] have been successfully used in the asymmetric
hydrosilylation of ketones.
In a recent paper by Inagaki et al.[85] the use of bis(oxazolinylphenyl)amine
(bopa, Figure 24) ligands in the Co and Fe catalyzed hydrosilylation of
acetophenones is described. They were able to reach full conversions and
excellent ee’s of up to 98 and 88% using cobalt and iron, respectively.
Figure 24: The Co- and Fe-Bopa catalysts (1.21) as used by Inagaki et al. in the
hydrosilylation of acetophenones.[85]
Until the beginning of 2010, only one paper had been published in which the use
of monodentate ligands in the hydrosilylation of ketones was reported. In 2001 it
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were Suárez et al.[87] which reported the use of monodentate phosphite ligands
obtaining up to 58% ee and 94% conversion in the rhodium-catalyzed
hydrosilylation of acetophenone. It took till 2010 before Junge et al. improved
this result using the from their group well known monodentate phosphepine
ligands.[88] They obtained good yields and up to 96% ee in the asymmetric
hydrosilylation of a broad range of ketones.[84]
1.4.4 Biocatalytic reductions
Besides chemical ways of reducing ketones also a biochemical pathway is
possible. The enzymes that are capable of reducing ketones into alcohols are
usually called alcohol dehydrogenases (ADH’s) but are also known under the
names ketoreductases and carbonyl reductases. Interesting enzymes have been
identified in a large number of bacteria, yeasts and fungi. Ways of doing
biochemical transformations can be divided into two main strategies:
1) Using whole cells
2) Using isolated enzymes
For both methods applies that the ketone is reduced by an enzyme with the
consumption of a co-factor molecule (usually NADH or NADPH). When using
whole cells, this co-factor is regenerated by other enzymes present in the cells
but when isolated enzymes are used this co-factor has to be added
stoichiometrically, which is very expensive, or a co-factor recycling system has
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Figure 25: General scheme for biocatalytic reduction of ketones.
Several recycling systems are in use nowadays, like formate dehydrogenase,
which transforms a molecule of formate into CO2 and OH– forming back one
molecule of NAD(P)H from NAD(P)+. In a similar fashion phosphite
dehydrogenase can be used regenerating NAD(P)H while transforming a
phosphite anion into a phosphate. The preferred recycling system however, uses
the enzyme glucose dehydrogenase (GDH) to convert NAD(P)+ back to
NAD(P)H using one molecule of glucose which is converted into gluconic acid.
The reason this system is preferred is the fact it is highly stable, active and it
accepts both cofactors. Drawbacks of this system are firstly that in order to
control the pH of the reaction medium the formed gluconic acid has to be
neutralized by addition of a base during the reaction, secondly GDH is not very
cheap. A cheaper method of reducing NAD(P)+ back to NAD(P)H is by using an
alcohol dehydrogenase (ADH) to oxidize ethanol or IPA to acetaldehyde or
acetone, respectively. Drawback of this method is the low oxidation potential
which makes it only available for the reduction of activated ketones.[89]
Over the years, several ADH’s have been identified and used in carbonyl
reductions reactions resulting in good conversions and excellent ee’s for a
variety of ketones[90;91] like acetophenones,[92-94] alkyl ketones,[93]
benzophenones,[95] and α-ketoesters.[96;97] Despite the good progress that has
been made, the major drawback of biocatalytic reactions still remains. Most of
the enzymes used in carbonyl reduction have a fairly narrow substrate scope that
gives good to excellent ee’s. Even a small difference in substitution pattern (e.g.
going from an H atom to an F atom) can lead to a significant drop in enzyme
activity and ee. Also the fact that usually only one of the two enantiomers of the
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product is accessible when using a particular enzyme can pose a problem and is
something that can easily be overcome in chemical asymmetric catalysis by
simply changing the enantiomer of the ligand used in the catalyst.
1.5 Phosphoramidites
As described above, phosphoramidite ligands were in 2000 one of three classes
of monodentate ligands which induced excellent enantioselectivities in the
rhodium catalyzed asymmetric olefin hydrogenation.[30] Since then, their easy
synthesis and high structural variability have made them interesting ligands for a
large number of asymmetric transformations which were recently extensively
reviewed.[98]
1.5.1 Synthesis of phosphoramidite ligands
One of the major advantages of the use of monodentate phosphoramidites over
the commonly used bidentate phosphorus ligands lies in their synthesis. Where
the synthesis of the bidentate ligands requires multiple steps, including some
very tedious ones,[99] the phosphoramidites can be readily synthesized in two or
three steps. There are different routes towards the various phosphoramidites but
the most common one, as depicted in Figure 25, starts off by a reaction of
inexpensive, enantiopure, bis-β-naphthol in refluxing PCl3 overnight to form the
phosphochloridite. After removal of the excess PCl3, the resulting chloridite is
redissolved in toluene and by adding the appropriate amine in combination with
Et3N, as an HCl scavenger, the phosphoramidite ligand is formed in moderate to
high yields. This simple two step synthesis route also proved to be very well
suited to be automated thus making it very easy to screen a large number of
ligands in a short period of time.[100-102]
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Figure 25: General scheme of the most common way of synthesizing phosphoramidite
ligands. Refluxing the diol overnight in PCl3 to form the phosphoryl chloride to which in
the presence of Et3N the desired amine can be coupled.
It is possible also, to start the synthesis of a phosphoramidite by transforming an
amine into its dichloroaminophosphine and then adding the diol.[103]
A third alternative is to perform a transamination by taking a phosphoramidite,
for instance MonoPhos, treat it with tetrazole and another amine. This results in
an almost quantitative exchange of the amine groups.[104]
Figure 26: Three ways of synthesizing a phosphoramidite ligand. (I) Formation of the
phosphoryl chloride from the diol followed by reaction with the desired amine. (II)
Formation of the “PCl2N” compound which is then reacted with the appropriate diol. (III)
Synthesis of MonoPhos and subsequent transamination in tetrazole to get the desired
ligand.
Of course, phosphoramidite ligands are not restricted to have a bis-naphthol
backbone. Several other diol backbones (see Figure 27) have been used
successfully in phosphoramidite synthesis. Among them substituted bis-
naphthols (1.22), biphenols (1.23), cathechol (1.24) and others.[30;105-108] The
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Figure 27: Examples of (a)chiral backbones, 8H-bis-β-naphthol (1.22), a biphenyl (1.23),
catechol (1.24) and taddol (1.25), which have been used successfully in the synthesis of
phosphoramidites.
1.5.2 Use of phosphoramidites in asymmetric hydrogenations
Since the discovery of the phosphoramidites as excellent ligands in the
asymmetric hydrogenation of dehydroamino acids[30] a range of different
substrates has been successfully hydrogenated using a catalyst based on
phosphoramidites.[38;39;105;107-116] A few examples of successful rhodium
catalyzed asymmetric hydrogenations, in which a phosphoramidite was used as
chiral ligand, are depicted in Figures 29-34
Figure 28: Enamide hydrogenation using MonoPhos as chiral ligand according to Van
den Berg et al..[115]
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Figure 29: α-dehydroamino acid hydrogenation using MonoPhos, PipPhos or MorfPhos
as chiral ligand by Van den Berg et al. and Bernsmann et al..[30;105]
Figure 30: β2-dehydroamino acid hydrogenation using 3-3’-dimethyl PipPhos according
to Hoen et al..[110]
Figure 31: carbamate hydrogenation using PipPhos according to Panella et al..[112]
Figure 32: Itaconic acid methyl ester hydrogenation using MonoPhos according to Van
den Berg et al..[116]
A procedure was reported in which a phosphoramidite ligand was made water-
soluble by attaching polyethyleneglycol units onto the backbone of the ligand. In




Figure 33: Asymmetric hydrogenation using a water soluble phosphoramidite ligand by
Hoen et al.[109]
Phosphoramidites have not only been used in the rhodium catalyzed
hydrogenation of olefinic double bonds. As already stated above, also in the
iridium catalyzed asymmetric hydrogenation of the C=N double bonds of
quino(xa)lines[38;111] and N-aryl imines[39] they perform excellent. When PipPhos
was used as a ligand in combination with its hydrochloric salt, full conversions
were reached in all three types of hydrogenations and ee’s up to 99% could be
obtained.
Figure 34: Quino(xa)line hydrogenation by Mršić et al.[38;111]
Figure 35: Imine hydrogenation by Mršić et al.[39]
When the iridium catalyzed hydrogenation of a dehydroamino acid was
performed using a phosphoramidite based on a biphenol backbone, an interesting
observation was made. It was found that when a biphenyl based Monophos type
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phosphoramidite was used with t-butyl side groups on the 3 and 3’ position only
one monodentate ligand was needed per iridium for excellent stereoselectivity
(Figure 36).[108] This was the first report in which only one monodentate ligand
per metal still gives excellent result in asymmetric hydrogenation.
Figure 36: Iridium catalyzed hydrogenation of dehydroamino acids using only one
monodentate ligand.[108]
1.5.3 Mixed ligands
Looking for a way to further improve the results in the asymmetric
hydrogenation using monodentate ligands, some groups decided to see what
would be the result if two different monodentate ligands are added to the catalyst
precursor. In this case several chiral catalytic species can be formed; the two
homo complexes, each containing two of the same ligands and a hetero complex
in which both ligands are present once.[117-122]
Figure 37: The different metal ligand complexes that are formed when using a mixed
ligand approach.
Depending on the most active and selective combination being formed by a self-
assembly process in the reaction mixture, the reaction rate and selectivity are
changed. This can lead to a great improvement in ee’s and reaction rate, even
when an achiral phosphine is used as second ligand. Hoen et al. were able to
improve the conversions and ee’s in the asymmetric hydrogenation of α,β-
disubstituted unsaturated acids by adding simple achiral triaryl phosphines to the
reaction mixture. In this way they were able to increase the rate up to tenfold and
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induce a rise in ee from 2% to 85% by simply adding triphenylphosphine to the
mixture. After a screening of different phosphines, it was found that when a
bulky triarylphosphine was added, the ee went even further up to an excellent
99%. The same positive influence of an additional achiral triarylphosphine was
found in the Ir-phosphoramidite catalyzed hydrogenation of quino(xa)lines and
N-aryl imines.[38;39;111] How the mixed ligand approach will affect the outcome of
the reaction is, however, not predictable beforehand and it is definitely not a
guarantee for better results (vide infra).
1.6 Goal of this research
In view of the excellent results obtained with monodentate phosphoramidite
ligands in the asymmetric hydrogenation of olefins, imines and heteroaromatics,
the logical next step was to study the enantioselective hydrogenation of C=O
double bonds using phosphoramidite ligands. Thus, we set out to develop one or
more catalytic systems for the asymmetric, ruthenium or iridium catalyzed,
hydrogenation of acetophenones, α- and β-ketoesters and α-aryl aldehydes.
1.7 Outline of the thesis
In this thesis the use of phosphoramidites as ligands in the hydrogenation of
several carbonyl compounds is described. Chapter two will focus on the
hydrogenation of simple aryl ketones, employing the classical Noyori type
catalyst using a combination of a chiral phosphorus ligand and a chiral
diamine.[44]
In chapter three, a switch is made from ruthenium to iridium as the metal of
choice. Ir/PPA and Ir/SPO catalysts were tested in the asymmetric
hydrogenation of a simple ketone.
In chapter four, the switch is made back again to ruthenium and the research
focuses on the use of the phosphoramidite ligands in the asymmetric
hydrogenation of α- and β-ketoesters.
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The good results that were obtained with the experiments in chapters two and
four are further explored in chapter five. In this chapter the results of the
asymmetric hydrogenation of α-substituted β-ketoesters and α-aryl aldehydes
under DKR conditions are described.
In the last chapter an overview is given of the conclusions drawn from this work
and an outlook for further research in the field of asymmetric hydrogenations
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Hydrogenation of Aryl Alkyl Ketones
using Phosphoramidite Ligands
Abstract
In this chapter the use of a ruthenium complex based on a chiral diamine and a
monodentate phosphoramidite as a catalyst for the asymmetric hydrogenation of aryl
alkyl ketones is described. The best catalyst contains 3,3’-dimethyl PipPhos and 1,2-
diamino-cyclohexane leading to full conversion and over 95% ee for a range of different
substrates. The exact structure of the complex is not yet fully established, although a lot
of evidence points towards a dimeric precatalyst containing just one phosphoramidite
ligand. We were able to prove that two phosphoramidite ligands per ruthenium are
necessary in order to obtain a high ee.
The work described here is covered by patent WO2008-077610 B. Stegink and J.G. de
Vries, “Asymmetric hydrogenation of prochiral compounds.”
Parts of this chapter are published: B. Stegink, L. van Boxtel, L. Lefort, A. J. Minnaard,




Even after the discovery of ruthenium-binap as catalyst for the asymmetric
hydrogenation of functionalized ketones by the group of Noyori,[1;2] the
acetophenone type ketones remained a problematic substrate for many years.
Figure 1: Noyori catalyst with an easy to hydrogenate, anchored, β-ketoester and a
difficult to hydrogenate, non-anchored, acetophenone.
The reason for this was the fact that in order to get good results, when using the
first Noyori type catalyst 2.1, the substrate needed to possess an anchoring group
which would keep the substrate in close proximity of the metal long enough for
the reaction to take place. As is shown in Figure 1, acetophenone, and other non-
functionalized ketones, do not possess such an anchoring group and therefore the
reduction was neither efficient nor selective.
Figure 2: The Noyori catalysts for the asymmetric hydrogenation of functionalized
ketones, without diamine (2.1) and for non-functionalized alkyl aryl ketones, with
diamine. (2.2)
It took until 1995 before Noyori and co-workers were able to hydrogenate these
substrates with high ee’s.[3;4] It was found that adding a chiral 1,2-diamine to the
catalyst improved the outcome of the reaction dramatically.
Besides the effect of the diamine they also found out that upon adding a small
amount of base to the reaction mixture they were able to speed up the reaction
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more than a 6000 fold compared to the original system without diamine and base,
creating one of the most efficient catalysts in homogeneous catalysis.[5]
One of the drawbacks of this type of catalysts is that substrates which do not
tolerate the presence of a base in the reaction can not be hydrogenated since the
base is needed for the activation of the catalyst. This problem was overcome by
treating the catalyst prior to use with 25 equivalents of NaBH4.[6]
Figure 3: The BH4-type Noyori catalyst which can be used under base-free conditions.
This led to a catalyst in which the two chlorides were replaced by a hydride and
a η1-HBH3 group. This catalyst proved to be active in the hydrogenation of non-
functionalized alkyl aryl ketones without adding a base to the mixture.
Since these discoveries numerous groups have developed their own catalysts for
the hydrogenation of acetophenones.[7;8] The differences between these systems
most often are found in the variation of the P-ligands. A few commonly used P-
ligands are depicted in Figure 4.
Figure 4: Representative examples of bidentate phosphine ligands that have been used
successfully in the asymmetric hydrogenation of alkyl aryl ketones.[8]
Surprisingly, only a few chiral diamines have ever been used as ligands. Almost
all groups use one of the three chiral 1,2-diamines depicted in Figure 5, 1,2-
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diphenyl ethylenediamine (DPEN), 1,2-diamino cyclohexane (DACH) or 1,1-
dianisole-2-isopropyl ethylenediamine (DAIPEN).
Figure 5: The three diamines most commonly used in the hydrogenation of
acetophenones.
There is however one diamine variation which increased the versatility of the
Noyori catalyst even further. The group of Noyori introduced the, non-chiral, α-
picolylamine (2.4) as an amine which made it possible to hydrogenate even the,
until then, very difficult substrate pinacolone (2.6).[9] They showed that by using
this amine instead of the classically used diamines these tert-butyl type
substrates could be hydrogenated in good yield and excellent enantioselectivities.
Figure 6: Picolylamine as used by Noyori to facilitate the hydrogenation of tert-butyl
ketones like pinacolone.
2.2 The mechanism
The hydrogenation of acetophenone using a Noyori-type catalyst proceeds via a
non-classical mechanism. In Figure 7 it can be seen that no direct interaction
between the substrate and the metal center of the catalyst takes place. Instead the
substrate binds in an outer sphere mode to the ligands of the catalyst before
being reduced.[10-14] The ruthenium dichloride catalyst precursor (I) is activated
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by the first equivalents of hydrogen under the influence of the base present
turning it into the dihydride species (II). To this complex, the substrate binds in
an outer sphere fashion in which one of the hydrides on the ruthenium center
coordinates to the more electrophilic carbon of the carbonyl and a proton of the
diamine coordinates to the more electronegative oxygen atom. In this way an,

















































Figure 7: Mechanism of hydrogenation of alkyl aryl ketones catalyzed by a Noyori type
catalyst.
The hydride and the proton are transferred to the substrate and the reduced
product is released. To the resulting complex (III) a hydrogen molecule binds
resulting in complex (IV) which then splits in one of two possible ways. Either it
heterolytically splits and regenerates the active catalyst via a four-membered
ring transition state (TS2), or the hydrogen splits heterolytically donating its



















which then donates its proton to the amine group regenerating the active
complex via a six-membered transition state (TS3). Whether the regeneration
goes via TS2 or TS3 depends on the nature of the solvent. In aprotic solvents the
route via TS2 will be followed whereas in protic solvents preferentially the TS3
route will be followed.
2.3 Monodentate ligands in acetophenone-type asymmetric ketone
hydrogenation
Until now only three reports are known in which a monodentate P-ligand is used
for the asymmetric hydrogenation of alkyl aryl ketones, all in combination with
a diamine co-ligand. The first report was from the group of Wills in 2004[15-17]
who described full conversions and excellent ee’s for a range of acetophenones
when using phosphonite (2.7) type ligands.
The second report came from the group of Ding[18] who was able to achieve
good chiral induction as well. Interestingly they used a non-chiral monodentate
phosphine and only a chiral diamine. They were able to reach up to 95% ee in
the hydrogenation of acetophenone using the bulky tris-(3,5-di(3,5-xylyl)-
phenyl)phosphine (2.8).
The third and final example came from the group of Lemaire[19] who used a P-
chiral monodentate phosphine ligand 2.9 with which they were able to get full
conversion and up to 61% ee in the hydrogenation of acetophenone, but only
when they use 1,4-butanediamine as co-ligand.
Figure 8: The monodentate P-ligands as used by the groups of Wills (2.7), Ding (2.8)
and Lemaire (2.9) in the hydrogenation of acetophenones.
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2.4 Goal of the research
Our group already has a lot of experience in using monodentate ligands in
asymmetric hydrogenation reactions.[20] As highlighted in chapter 1,
phosphoramidite ligands are an interesting class of ligands to use because of
their structural versatility, easy synthesis which is highly suited for high
throughput screening and relatively cheap starting materials. We set out to
further optimize the preliminary results obtained in DSM and create a
ruthenium-based catalyst containing monodentate phosphoramidite ligands
which would be able to hydrogenate acetophenone-type ketones in good yields
and high ee’s. The results obtained in this search for a good catalyst will be
discussed in this chapter.
2.5 Results
Early 2005 some promising results were obtained at DSM in the first attempts of
the asymmetric hydrogenation of acetophenone using a ruthenium catalyst
containing phosphoramidite ligands. When using a ruthenium catalyst containing
two phosphoramidites and a (chiral) diamine they were able to get up to 61% ee
in the hydrogenation of acetophenone, at 50 bar and 50 oC.[21] To further
optimize the results previously obtained in DSM we started with a
phosphoramidite ligand screening.
As a starting point for the preparation of the pre-catalyst we used the catalyst
preparation first described by Noyori[3] which has since then been used by most
groups working in this field.
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Figure 9: Preparation of the precatalyst for the hydrogenation of ketones.
As can be seen in Figure 9 the pre-catalyst was made by adding 4 equivalents of
a monodentate phosphoramidite to the dimeric ruthenium precursor
[RuCl2(cymene)]2. This mixture was heated in DMF for 3 h at 90 oC. After
cooling the mixture down to room temperature, two equivalents of the desired
1,2-diamine were added and after overnight stirring the precatalyst was obtained
by evaporating the DMF, stripping the residue twice with toluene and washing it
twice with hexane, which should wash away any free ligand still present. The
obtained powder was used directly in the hydrogenations. The precatalyst would
be activated by the first equivalents of hydrogen gas after addition of base to the
reaction mixture as has been previously shown in the mechanistic studies of
similar catalysts (see also Figure 7 for the reaction mechanism).[12]
2.5.1 Screening of ligands
The search for a fast and enantioselective ketone hydrogenation catalyst started
with a screening of phosphoramidite ligands. They were tested as P-ligands in
the hydrogenation of acetophenone. As standard conditions 0.1 mol% ruthenium
catalyst was used in the presence of 1 mol% of KOtBu. The reaction mixtures
were kept stirring in the Endeavor, a unit containing eight small stirred
autoclaves, for 16 h under a hydrogen pressure of 25 bar. The results of this
initial screening are depicted in Table 1. In all cases the catalysts displayed
perfect chemoselectivity towards the carbonyl group, (partial) reduction of the
aryl groups was never observed. The first try, using normal PipPhos (L1)
immediately gave full conversion and an ee of 52%. In an attempt to improve
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this ee a few other ligands were tested. The first thing we tried was to investigate
whether a bidentate phosphoramidite ligand would give better selectivities. We
tested three bidentate ligands (L3, L4 and L8) with no success. In all three cases
the ee turned out to be lower compared to the result with PipPhos as ligand. This,
in combination with the fact that none of the reactions went to completion within
the 16 h reaction time, made us decide to shift our focus back to the
monodentate ligands.
The “Leggy”-ligand L2 with a more bulky amine did also not give an
improvement in terms of ee. Going to a smaller backbone by using a catechol
based ligand L5, which gave good results in the olefin hydrogenations,[22] proved
to be the worst choice of all, giving only 40% conversion and a racemic product.
When, however, the backbone of the ligand was made bulkier, instead of smaller,
by adding two methyl groups on the 3 and 3’ position of the naphthyl unit the ee
went up significantly. When 3,3’-dimethyl MonoPhos (L6) was used, the ee
already increased to 90%, even exceeding the result obtained with Binap (entry 1)
as a ligand. With DiMePip (L7) the ee went up even further to reach an excellent
97%.
Switching from the diamine DPEN to DACH proved not to be of influence on
the outcome of the reaction (entry 8 vs. entry 11). The use of the non-chiral
diamine 1,2-ethylenediamine (entry 13), however, made the importance of the
chirality of the diamine co-ligand in the catalyst very clear, as this change
resulted in a drop in ee to just 34%. Switching the stereochemistry of the
diamine resulted in a drop in ee from 97% to 52% (entries 11 and 12). These
results made it clear that there is a matched combination, with both the
phosphoramidite and the diamine of the same absolute configuration, and a
mismatched combination, with the phosphoramidite and the diamine both of
opposite absolute configurations, of phosphoramidite and diamine and the best
selectivities are achieved only when the phosphoramidites and diamine present
are of the same absolute configuration.
To make sure the reaction is only operating through molecular hydrogen and no
other background reactions with the substrate, such as transfer hydrogenation,
take place, we also tried the reduction of acetophenone in the absence of
hydrogen pressure. As can be seen in entry 14 no reaction takes place at all,
establishing it is really a reduction by molecular hydrogen we are looking at.
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Table 1: Ligand screening in the acetophenone hydrogenation.
Ligand Diamine Conversiona (%) Eea (%)
1 (S)-Binap (S,S)-DPEN 100 87 (R)
2 (S)-L1 (S,S)-DPEN 100 52 (R)
3 (S,RR)-L2 (S,S)-DPEN 100 41 (R)
4 (S)-L3 (S,S)-DPEN 50 12 (R)
5 (S)-L4 (S,S)-DPEN 20 10 (R)
6 (R,R)-L5 (R,R)-DPEN 40 rac.
7 (R)-L6 (R,R)-DPEN 100 90 (S)
8 (R)-L7 (R,R)-DPEN 100 97 (S)
9 (S)-L8 (S,S)-DPEN 13 41 (R)
10 (S)-L1 (S,S)-DACH 100 55 (R)
11 (R)-L7 (R,R)-DACH 100 97 (S)
12 (R)-L7 (S,S)-DACH 100 52 (S)
13 (R)-L1 Ethylenediamine 100 34 (S)
14b (R)-L7 (R,R)-DACH 0 Nd
All reactions were carried out in the Endeavor parallel autoclave on 2 mmol of 2.10a in a
total volume of 4 ml iPrOH with 0.1 mol% catalyst in the presence of 1 mol% KOtBu.
Hydrogen pressure was applied (25 bar) for 16 h while the reaction was stirred at room
temperature. a) Conversion and ee were determined using 1H-NMR and chiral GC,
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2.5.2 Substrate scope
Having established the best phosphoramidite-diamine combination, DiMePip
and DACH, the scope of the reaction was screened. As can be seen in Table 2
the system works very well for a large range of aromatic ketones. With most
substrates it is possible to reach full conversion within 16 h. Only a few
substrates are not hydrogenated to completion. o-Hydroxy acetophenone (2.10c)
did not react at all which is probably due to the acidity of the substrate. The base
that is added to the reaction mixture will immediately react with the phenol
group of the substrate which prevents the catalyst from being activated. If the
protected substrate, o-methoxy acetophenone (2.10d), is used the activity is
restored again. Other problematic substrates are the sterically demanding 2-
methyl-propiophenone (2.10m, entry 14) and the two substrates bearing
strongly electron withdrawing substituents (2.10o-p entries 16 and 17). The
selectivity of the hydrogenations is mostly excellent (ee >90%) except for the
meta-substituted substrates where the enantiomeric excess drops.
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Table 2: Substrate scope of the aromatic ketone hydrogenation.
Substrate R1 R2 Conversiona (%) Eea (%)
1 2.10a H Me 100 97 (S)
2 2.10b o-Me Me 100 97 (S)
3 2.10c o-OH Me 0 Nd
4 2.10d o-OMe Me 100 96 (S)
5 2.10e p-OMe Me 100 97 (S)
6 2.10f p-Cl Me 100 95 (S)
7 2.10g m-Br Me 100 65 (S)
8 2.10h m-Cl Me 100 83 (S)
9 2.10i m-OMe Me <10 Nd







13 2.10k H Et 100 91 (S)
14 2.10m H i-Pr <10 Nd
15 2.10n H n-Pr 100 93 (S)
16 2.10o H CH2Cl <10 Nd
17 2.10p H CF3 <10 Nd
18 2.10q o-Me Ph 100 15 (R)
All reactions were carried out in the Endeavor parallel autoclave on 2 mmol substrate in
a total volume of 4 ml iPrOH with 0.1 mol% catalyst, containing DiMePip and DACH as
ligands, in the presence of 1 mol% KOtBu. Hydrogen pressure was applied (25 bar) for
16 h while the reaction was stirring at room temperature. a) Conversion and ee were
determined using 1H-NMR and chiral GC respectively.
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After testing a range of aromatic ketones we decided to investigate if the catalyst
would also be able to hydrogenate alkyl ketones. As can be seen in Table 3
varying results were obtained.
Table 3: Results in the hydrogenation of aliphatic ketones.
Entry Substrate R1 R2 Conversiona (%) eea (%)
1 2.6 Me t-Bu 50 41 (S)
2 2.16 Me Bu 100 <5
3 2.17 2-cyclohexenone 85 <5
All reactions were carried out in the Endeavor parallel autoclave on 2 mmol substrate in
a total volume of 4 ml iPrOH with 0.1 mol% catalyst, containing DiMePip and DACH as
ligands, in the presence of 1 mol% KOtBu. Hydrogen pressure was applied (25 bar) for
16 h while the reaction was stirring at room temperature. a) Conversion and ee were
determined using chiral GC.
In the case of the, known to be difficult[9], substrate pinacolone (2.6, entry 1) the
reaction did not proceed for more than 50%. There was some selectivity towards
one of the two enantiomers but with an ee of 41% this is not very impressive.
The hydrogenation of 2-hexanone (2.16, entry 2) did go to full completion.
However, since no significant ee was found, the small difference between the
methyl and butyl groups of the molecule apparently made it almost impossible
for the catalyst to create any selection towards one of the two enantiomers. In the
case of 2-cyclohexenone (2.17, entry 4) the conversion, although not complete,
was good, also the hydrogenation went with complete selectivity for the
carbonyl group. Products with a saturated cyclohexane ring were not detected.




As already mentioned in chapter 1, it is known from earlier work by the groups
of Reetz[23;24] and our own[25;26] that mixing of monodentate chiral ligands with
monodentate (a)chiral ligands can have a dramatic influence on the rate and
enantioselectivity in the asymmetric hydrogenation of olefins. By mixing
different monodentate ligands together in the reaction mixture, different metal
ligand combinations can be formed (see Figure 10). In some cases the hetero
combinations formed can outperform the homo combinations giving rise to
faster and more selective reactions.
Figure 10: Schematic representation of the metal ligand combinations formed when
using a mixed ligand approach.
We decided to examine if the same observations could be made in the
hydrogenation of aryl ketones. To see if the mixed ligand approach would have
the same positive outcome as in the olefin hydrogenations we preformed a
dimeric precatalyst (vide infra) containing one ligand (R)-L7 and one (R,R)-
DACH molecule per ruthenium center. This dimeric complex was used in the
hydrogenation of acetophenone with extra ligand added to it.






1 0 1 full (16 h) 97
2 1 0 full (13 h) 52
3 2 0 full (8 h) 28
Substrate 2.10a was hydrogenated in iPrOH under 25 bar H2 pressure, using 1 mol% of
KOtBu and 0.05 mol% “[RuCl2(L7)(DACH)]2 ” to which the given amount of PPh3
and/or DiMePip were added prior to pressurizing the autoclave. a) Given number is
number of equivalents wrt the amount of ruthenium. b) Conversions were monitored
using the Endeavor parallel autoclave gas uptake graph c) ee was determined via chiral
GC.
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As can be seen in Table 4 the results were not the same as for the olefin
hydrogenation. The dimeric complex performed equally well, compared to the
previous results, if an extra equivalent of L7 was added to the reaction mixture.
Upon adding triphenylphosphine to the reaction mixture the reaction rate was
enhanced. Two equivalents of PPh3 added to the reaction mixture made the
reaction time drop by 8 h. The product, however, had a much lower ee compared
to the product of the reaction without added triphenylphosphine. It looks like the
complex with the highest catalytic activity bears achiral triphenylphosphine
ligands, which lead to a higher reaction rate but also less selectivity.
2.6 Characterization of the complex
When analyzing the complex we used for the hydrogenation experiments
containing two phosphoramidites and a diamine ligand per ruthenium center, the
first observations we made were the two absorptions in the 31P-NMR spectrum
(Figure 11). The chemical shift of the two absorptions corresponded nicely to
that of free ligand (147 ppm) and to that of a phosphoramidite coordinated to
ruthenium (173 ppm).[27;28] This observation was somewhat puzzling since we
expected only one absorption, namely that of bound phosphoramidite ligand.
Figure 11: 31P-NMR (CDCl3) of the complex made with two PPA's per Ru center.
The mass spectrum that was recorded from the complex did not show the
expected mass of 1104 [M-Cl]+ corresponding to the ruthenium complex
containing two phosphoramidite ligands, a diamine and one chloro atom. Instead
a peak was found at a much higher m/z ratio of 1389. The isotope pattern of the
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spectrum suggested the presence of a dimeric ruthenium complex (2.21)
containing only one phosphoramidite ligand per ruthenium center in
combination with one diamine and two chloride ions.
Figure 12: Dimeric complex based upon the mass spectrum results.
With L = monodentate phosphoramidite ligand.
When we tried to preprepare the complex with only one ligand per ruthenium
center instead of two, a complex was obtained which was still an active catalyst
(see Table 5, entry 1). As can be seen in Figure 13 the 31P-NMR of this complex
still showed the presence of some free phosphoramidite ligand in solution,
indicating an indeed very weak coordination of the phosphoramidite to the
ruthenium. It was previously found in DSM, that after an overnight washing step
with hexane after the complex preparation, no phosphoramidite was found to be
present in the complex.[29] This also indicates weak ligand coordination to the
ruthenium center.
Figure 13: 31P-NMR (CDCl3) of complex made with one equivalent PPA per Ru center.
The complex obtained with the adjusted preparation method of adding only one
phosphoramidite per ruthenium proved to be able to get the hydrogenation
reaction to completion, although with lower selectivity as can be seen from the
result in entry 1 in Table 5.
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Table 5: Adding extra ligand to the preformed catalyst.
“catalyst”a Extra ligandb Conversionc (%) Eed (%)
1 RuCl2(L)(DACH) 0 100 (18h) 75
2 RuCl2(L)(DACH) 0.5 (DiMePip) 100 (17h) 90
3 RuCl2(L)(DACH) 1.0 (DiMePip) 100 (16h) 97
4 RuCl2(L)(DACH) 1.5 (DiMePip) 100 (14h) 89
5 RuCl2(L)(DACH) 0.5 (PPh3) 50 (24h) 31
6 RuCl2(L)(DACH) 1.0 (PPh3) 50 (24h) 38
Substrate 2.10a was hydrogenated in iPrOH under 25 bar H2 pressure, using 1 mol% of
base and 0.1 mol% “Ru” to which the given amount of extra ligand was added prior to
pressurizing the autoclave. a) The catalyst was added as 0.05 mol% dimer; L = (R)-
DiMePip; DACH = (R,R)-DACH. b) given number is number of equivalents wrt the
amount of ruthenium. c) Conversions were monitored using the Endeavor parallel
autoclave gas uptake graph. d) ee was determined via chiral GC.
Adding one equivalent of ligand to the reaction mixture just before placing it in
the Endeavor proved to work in restoring the selectivity to the original. Adding
more than one extra equivalent led to an, although faster, less selective reaction
again. Surprisingly adding PPh3 in this case did not speed up the reaction, as was
the case when the catalyst was preprepared with two ligands per metal center,
but slowed it down significantly.
Since the mass spectrum did not give a conclusive results about the nature of the
complex we decided to try to grow crystals for X-ray analysis to get a better
insight into how the different ligands are arranged around the metal center. This
proved to be a difficult task. In the end we were able to grow some crystals
which were suitable for X-Ray analysis. To our surprise however, the X-Ray
structure showed no phosphoramidites were present at all bound to the metal
center but only the diamine was present together with one of the cymene
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molecules. Not finding any phosphoramidite in the crystal structure was very
surprising to us but does relate to the previously described findings done at DSM
where no phosphoramidite was found in the complex after a prolonged washing
step. Since the growing of the crystals took several days this could also been
seen as such a washing.
Experimental results, however, still show that the presence of the
phosphoramidites play a crucial role in the selectivity of the reaction. As is
clearly shown in Table 5, adding extra ligand to the reaction mixture is
necessary in order to reach the optimal selectivity. This suggests that during the
catalytic cycle the ligands definitely play a role in the reaction and the selectivity
of the reaction is not only determined by the diamine. This is also suggested by
the different results obtained when different phosphoramidites are being used
(see Table 1). Despite the fact that the different analyses done on the complex,
NMR, mass and X-Ray, do not clearly show the presence of phosphoramidite
ligands around the metal, we think it is safe to say they are present around the
ruthenium center during the hydrogenation reaction.
2.7 Conclusions
It was found that phosphoramidite ligands can be used as ligands in the
asymmetric hydrogenation of aromatic ketones. When 3,3’-dimethyl PipPhos is
used in combination with DACH or DPEN, the ruthenium catalyzed
hydrogenations go to full conversion and provide the product with over 95% ee
for a range of acetophenone derivatives. The exact structure of the catalyst
turned out to be harder to prove than expected but all the results of the
hydrogenation experiments point towards a catalyst which carries two
phosphoramidite ligands per ruthenium in the catalytic cycle.
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Starting materials were purchased from Aldrich, Alfa Aesar or Acros and used as
received unless stated otherwise. [RuCl2(cymene)]2 was bought from Strem and used as
received. (R)-3,3’-dimethyl bis-β-naphthol was kindly provided by DSM. All solvents
were reagent grade and, if necessary, dried and distilled prior to use. Column
chromatography was performed on silica gel (Aldrich 60, 230-400 mesh). TLC was
performed on silica gel 60/Kieselguhr F254. 1H and 13C NMR spectra were recorded on a
Varian AMX400 (399.93 MHz for 1H, 100.59 MHz for 13C and 161.9 MHz (1H-
decoupled) for 31P) spectrometer or a Mercury-200 (199.99 MHz for 1H and 50.3 MHz
for 13C). Mass spectra (HRMS) were performed on a Jeol JMS-600H.
Synthesis of (L7) (R)-1-(2,6-dimethyl-3,5-dioxa-4-phosphacyclohepta[2,1-a;3,4-
a']dinaphthalen-4-yl)piperidine; ((R)-DiMePipPhos)
(R)-3,3’-Dimethyl-bis-β-naphthol, (2 g. 6.4 mmol), was
dissolved in 10 ml of PCl3. After heating overnight at reflux
the excess of PCl3 was distilled of in vacuo. The residual solid
was subjected to azeotropic distillation with toluene (2 x 10
ml), affording the crude chlorophosphite.
The chlorophosphite was redissolved in toluene (10 ml). To the solution 2 ml Et3N (14.1
mmol, 2.2 equiv) was added, followed by 0.7 ml piperidine (7 mmol, 1.1 equiv) in small
portions. After two hours of stirring 10 ml MTBE was added. The resulting suspension
was filtered over Celite and concentrated. The residue was purified over SiO2 using
pentane : ethyl acetate (9:1) as eluent, affording 1.9 g (4.4 mmol, 68%) of the pure solid
white product.
1H (400 MHz, CDCl3) δ (ppm) 7.79-7.71 (m, 4H), 7.34-7.11 (m, 6H), 2.94-2.85 (m, 4H),
2.53 (d, J = 29 Hz, 6H), 1.51-1.47 (m, 2H), 1.39-1.28 (m, 4H); 31P (161 MHz, CDCl3) δ
(ppm) 143.0.
A typical precatalyst synthesis: Synthesis of [RuCl2((R)-3-3’-DiMe-PipPhos)2((R,R)-
DACH)]
A Schlenk flask was flame-dried and 62 mg [RuCl2(cymene)]2 (0.1 mmol) and 171 mg
(R)-3-3’-Dimethyl-PipPhos (0.4 mmol, 4 equiv.) were added. The Schlenk flask was
degassed by three cycles of vacuum/N2 and then put under N2 and the solids were
dissolved in 5 ml DMF. This mixture was heated for 3 h at 90 oC and subsequently the
mixture was cooled to room temperature and 23 mg (R,R)-DACH (0.2 mmol, 2 equiv.)
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was added. The solution was stirred overnight after which the DMF was evaporated
under reduced pressure. The resulting solid mass was subjected to azeotropic distillation
with toluene (2 x 5 ml) and washed twice with 5 ml hexane. The obtained solid was used
in hydrogenation reactions without further purification.
1H-NMR (400 MHz, CDCl3) δ (ppm): 8.05 (d, 1H, J = 36 Hz), 7.90-7.70 (m, 6H), 7.39-
7.11 (m, 13H), 5.87 (dd, 2H, J = 22 Hz, J = 120 Hz), 5.85 (d, 2H, J = 22 Hz), 2.95-2.51
(m, 15H), 2.37-2.36 (m, 6H) 1.99-0.79 (m, 50H). 31P-NMR (161 MHz, CDCl3): δ (ppm):
173, 147.
A typical precatalyst synthesis: Synthesis of [RuCl2(DiMePip)(DACH)]2
A Schlenk flask was flame-dried and 62 mg [RuCl2(cymene)]2 (0.1 mmol) and 85 mg
(R)-3,3‘-dimethyl PipPhos (0.2 mmol, 2 equiv.) were added. The Schlenk flask was
degassed by three cycles of vacuum/N2 and then put under N2. The solids were dissolved
in 5 ml DMF. This mixture was heated for 3 h at 90 oC. Subsequently the mixture was
cooled down to room temperature and 23 mg (R,R)-DACH (0.2 mmol, 2 equiv.) was
added. The solution was stirred overnight after which the DMF was evaporated under
reduced pressure. The resulting solid mass was subjected to azeotropic distillation with
toluene (2 x 5 ml) and washed twice with 5 ml hexane. The obtained solid was used in
hydrogenation reactions without further purification up on adding an extra equivalent of
ligand per ruthenium center.
1H-NMR (400 MHz, CDCl3) δ (ppm): 8.05 (d, 1H, J = 36 Hz), 7.90-7.70 (m, 6H), 7.39-
7.11 (m, 13H), 5.87 (dd, 2H, J = 22 Hz, J = 120 Hz), 5.85 (d, 2H, J = 22 Hz), 2.95-2.51
(m, 15H), 2.37-2.36 (m, 6H) 1.99-0.79 (m, 50H). 31P-NMR (161 MHz, CDCl3): δ (ppm):
173 (major), 147 (minor).
A typical procedure for the hydrogenation of acetophenones using [RuCl2(L)2(diamine)]
To a glass liner for the Endeavor, 2 mmol of substrate and 2 μmol of preformed catalyst
(0.1 mol%) were added. The compounds were dissolved in 4 ml i-PrOH. To the resulting
solution, 10 μl of a 1 M solution of KOtBu in i-PrOH was added just prior to inserting
the liner into the Endeavor parallel autoclave. After the Endeavour was tightly closed,
the system was purged 3 times with 5 bar N2 and 3 times with 5 bar H2, while stirring at
400 rpm. After the six purging cycles the stirring speed was increased to 750 rpm and a
pressure of 25 bar H2 was applied. This situation was kept for 24 h, subsequently the
Endeavor was carefully vented and opened and the glass liner was taken out. From the
reaction mixture a sample was taken and run over a silica plug to prepare a GC sample.
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A typical procedure for the hydrogenation of acetophenones using [RuCl2(L)(diamine)]2
To a glass liner for the Endeavor, 2 mmol of substrate was added. To the substrate 1
μmol of preformed complex (0.05 mol%) and 2 μmol ligand (0.1 mol%) were added.
Everything was dissolved in 4 ml i-PrOH. Just prior to inserting the liner into the
Endeavor 10 μl of a 1 M solution of KOtBu in i-PrOH was added to the mixture. After
the Endeavour was tightly closed the system was purged 3 times with 5 bar N2 and 3
times with 5 bar H2, while stirring at 400 rpm. After the six purging cycles the stirring
speed was increased to 750 rpm and a pressure of 25 bar H2 was introduced. This
situation was kept for 24 h, subsequently the Endeavor was carefully vented and the
glass liner taken out. From the reaction mixture a sample was taken and run over a silica
plug to prepare a GC sample.
All alcohols described below were obtained after a hydrogenation using a
[RuCl2(L)(diamine)]2 type catalyst in which L = (R)-3-3’dimethyl PipPhos and the
diamine (R,R)-DACH. To the reaction mixture one equivalent of (R)-3-3’-dimethyl
PipPhos per ruthenium center was added.
(S)-1-phenyl ethanol (2.11a)[16] was obtained as a colorless oil (full conversion, 92%
isolated yield, 97% ee), 1H-NMR (200 MHz, CDCl3) δ (ppm): 7.37-7.26 (m, 5H), 4.85
(q, J = 6.4 Hz, 1H), 2.49 (s, 1H), 1.48 (d, J = 6.4 Hz, 3H). 13C-NMR (50 MHz, CDCl3) δ
(ppm): 144, 127, 126, 124, 68, 23. [α]D = −48.9 (c 1.0, CHCl3). Ee was determined using
a Chiralsil DEX-CB column (25m x 250 μm x 0.25 μm) Tinlet = Tdet = 250 oC; Tstart = 110
oC (isotherm); TS = 7.5 min, TR = 7.2 min.
(S)-1-(2-methyl phenyl) ethanol (2.11b)[16] was obtained as a light yellow oil (full
conversion, 96% isolated yield, 97% ee), 1H-NMR (200 MHz, CDCl3) δ (ppm): 7.52 (d,
J = 7.9 Hz, 1H), 7.27-7.02 (m, 3H), 5.17 (q, J = 6.4 Hz, 1H), 2.35 (s, 3H), 1.76 (bs, 1H),
1.47 (d, J = 6.4, 3H Hz). 13C-NMR (50 MHz, CDCl3) δ (ppm): 144, 134, 130, 127, 126,
124, 67, 24, 19. [α]D = −62.8 (c 1.09, CHCl3). Ee was determined using a Chiralsil DEX-
CB column (25m x 250 μm x 0.25 μm) Tinlet = Tdet = 250 oC; Tstart = 110 oC (25 min) –
(10 oC / min) 180 oC. TS = 13.6 min; TR = 12.0 min.
(S)-1-(2-methoxyphenyl) ethanol (2.11d)[30] was obtained as a yellow oil (full
conversion, 96% ee), 1H-NMR (200 MHz, CDCl3) δ (ppm): 7.39-7.19 (m, 2H), 7.00-
6.83 (m, 2H), 5.09 (quin, J = 6.4 Hz, 1H), 3.87 (s, 3H), 2.59 (bs, 1H), 1.51 (d, J = 6.4 Hz,
3H). 13C-NMR (50 MHz, CDCl3) δ (ppm): 156, 134, 128, 126, 121, 110, 67, 55, 23. [α]D
= −18.9 (c 0.98, CHCl3). Ee was determined using a Chiralsil DEX-CB column (25m x
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250 μm x 0.25 μm) Tinlet = Tdet = 250 oC; Tstart = 110 oC (isotherm); TS = 20.1 min, TR =
19.2 min.
(S)-1-(4-methoxyphenyl) ethanol (2.11e)[31] was obtained as a brown oil (full
conversion, 97% ee), 1H-NMR (200 MHz, CDCl3) δ (ppm): 7.32-7.26 (m, 2H), 6.92-
6.86 (m, 2H), 4.85 (q, J = 6.5 Hz, 1H), 3.80 (s, 3H), 1.79 (bs, 1H), 1.48 (d, J = 6.5 Hz,
3H). 13C-NMR (50 MHz, CDCl3) δ (ppm): 158, 138, 127, 114, 70, 55, 25. [α]D = −52.1
(c 1.08, CHCl3). Ee was determined using a Chiralsil DEX-CB column (25m x 250 μm x
0.25 μm) Tinlet = Tdet = 250 oC; Tstart = 110 oC (isotherm); TS = 11.9 min, TR = 11.5 min.
(S)-1-(4-chlorophenyl) ethanol (2.11f)[16] was obtained as a yellow oil (full conversion,
95% ee), 1H-NMR (200 MHz, CDCl3) δ (ppm): 7.31-7.26 (m, 4H), 4.88 (q, J = 6.8 Hz,
1H), 1.86 (bs, 1H), 1.47 (d, J = 6.5 Hz, 3H). 13C-NMR (50 MHz, CDCl3) δ (ppm): 144,
133, 129, 127, 70, 25. [α]D = −47.9 (c 0.98, CHCl3). Ee was determined using a Chiralsil
DEX-CB column (25m x 250 μm x 0.25 μm) Tinlet = Tdet = 250 oC; Tstart = 110 oC
(isotherm); TS = 15.8 min, TR = 15.3 min.
(S)-1-(3-bromophenyl) ethanol (2.11g)[32] was obtained as a brown oil (full conversion,
65% ee), 1H-NMR (200 MHz, CDCl3) δ (ppm): 7.58 (s, 1H), 7.42-7.37 (m, 1H), 7.32-
7.21 (m, 2H), 4.83 (q, J = 6.5 Hz, 1H), 1.86 (bs, 1H), 1.49 (d, J = 6.5 Hz, 3H). 13C-NMR
(50 MHz, CDCl3) δ (ppm): 148, 131, 130, 129, 124, 123, 70, 25. [α]D = −20.8 (c = 1.03,
CHCl3). Ee was determined using a Chiralsil DEX-CB column (25m x 250 μm x 0.25
μm) Tinlet = Tdet = 250 oC; Tstart = 110 oC (isotherm); TS = 28.3 min, TR = 17.2 min.
(S)-1-(3-chlorophenyl) ethanol (2.11h)[16] was obtained as a brown oil (full conversion,
83% ee), 1H-NMR (200 MHz, CDCl3) δ (ppm): 7.39 (s, 1H), 7.23-7.19 (m, 3H), 4.86 (q,
J = 6.5 Hz, 1H), 1.83 (bs, 1H), 1.49 (d, J = 6.5 Hz, 3H). 13C-NMR (50 MHz, CDCl3) δ
(ppm): 148, 130, 128, 126, 124, 70, 25. [α]D = −36.2 (c 1.01, CHCl3). Ee was determined
using a Chiralsil DEX-CB column (25m x 250 μm x 0.25 μm) Tinlet = Tdet = 250 oC; Tstart
= 110 oC (isotherm); TS = 16.4 min, TR = 14.9 min.
(S)-1-(3,5-di(trisfluoromethyl)phenyl) ethanol (2.11j)[33] was obtained as a colorless
oil (full conversion, 95% ee), 1H-NMR (200 MHz, CDCl3) δ (ppm): 7.85 (s, 2H), 7.79 (s,
1H), 5.05 (q, J = 6.6 Hz, 1H), 2.03 (bs, 1H), 1.55 (d, J = 6.6 Hz, 3H). Ee was determined
using a Chiralsil DEX-CB column (25m x 250 μm x 0.25 μm) Tinlet = Tdet = 250 oC; Tstart
= 110 oC (isotherm); TS = 5.8 min, TR = 6.5 min.
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(S)-1-phenyl propanol (2.11k)[16] was obtained as a dark yellow oil (full conversion,
91% ee), 1H-NMR (200 MHz, CDCl3) δ (ppm): 7.37-7.20 (m, 5H), 4.59 (t, J = 7.4 Hz,
1H), 1.86-1.68 (m, 3H), 0.92 (t, J = 7.4 Hz, 3H). 13C-NMR (50 MHz, CDCl3) δ (ppm):
144, 128, 127, 126, 76, 32, 10. [α]D = −42.4 (c 0.93, CHCl3). Ee was determined using a
Chiralsil DEX-CB column (25m x 250 μm x 0.25 μm) Tinlet = Tdet = 250 oC; Tstart = 110
oC (isotherm); TS = 12.1 min, TR = 11.5 min.
(S)-1-phenyl butanol (2.11n)[34] was obtained as a white solid (full conversion, 96%
isolated yield, 93% ee), mp = 45.9 - 46.1 oC. 1H-NMR (200 MHz, CDCl3) δ (ppm): 7.41-
7.19 (m, 5H), 4.68 (t, J = 5.9 Hz, 1H), 1.87-1.21 (m, 5H), 0.93 (t, J = 7.4 Hz, 3H). 13C-
NMR (50 MHz, CDCl3) δ (ppm): 128, 127, 126, 54, 41, 19, 14. [α]D = −44.2 (c 0.99,
CHCl3). Ee was determined using a Chiralsil DEX-CB column (25m x 250 μm x 0.25
μm) Tinlet = Tdet = 250 oC; Tstart = 120 oC (2 min) - (1 oC / min) - 180 oC; TS = 12.5 min,
TR = 11.5 min.
(R)-Phenyl-o-tolylcarbinol (2.11q) Conversion (100%) and ee (15%) were determined
using a Chiralsil DEX-CB column (25m x 250 μm x 0.25 μm) Tinlet = Tdet = 250 oC; Tstart
= 160 oC (60 min) - (1 oC / min) 170 oC. TS = 61.1 min; TR = 63.5 min.
(S)-1-naphthyl ethanol (2.14)[16] was obtained as a green oil (full conversion, 93% ee),
1H-NMR (200 MHz, CDCl3) δ (ppm): 8.19-8.11 (m, 1H), 7.91-7.83 (m, 1H), 7.79 (d, J =
7.0 Hz, 1H), 7.68 (d, J = 7.6 Hz, 1H), 7.59-7.42 (m, 3H), 5.78-5.59 (m, 1H), 1.99 (bs,
1H), 1.69 (d, J = 6.5 Hz, 3H). 13C-NMR (50 MHz, CDCl3) δ (ppm): 142, 134, 130, 129,
128, 126, 125, 123, 122, 67, 24. [α]D = 71.6 (c 0.96, CHCl3). Ee was determined using a
Chiralsil DEX-CB column (25m x 250 μm x 0.25 μm) Tinlet = Tdet = 250 oC; Tstart = 140
oC (isotherm); TS = 62.2 min, TR = 59.9 min.
(S)-2-naphthyl ethanol (2.15)[31] was obtained as a white solid (full conversion, 94%
ee), mp = 70.1 - 70.9 oC. 1H-NMR (200 MHz, CDCl3) δ (ppm): 7.82-7.79 (m, 3H), 7.52-
7.41 (m, 3H), 7.26 (s, 1H), 5.07 (q, J = 6.5 Hz, 1H), 1.92 (bs, 1H), 1.59 (d, J = 6.5 Hz,
3H). 13C-NMR (50 MHz, CDCl3) δ (ppm): 143, 129, 128, 128, 127, 126, 124, 70, 25.
[α]D = −47.8 (c 1.12, CHCl3). Ee was determined using a Chiralsil DEX-CB column
(25m x 250 μm x 0.25 μm) Tinlet = Tdet = 250 oC; Tstart = 120 oC (2 min) - (1 oC / min) –
180 oC; TS = 31.1 min, TR = 30.5 min.
Chapter 2
68
(S)-3,3-dimethyl butan-2-ol (2.18) Conversion (50%) and ee (41%) were determined
using a GTA column (25m x 250 μm x 0.25 μm) Tinlet = Tdet = 250 oC; Tstart = 70 oC (35
min) – (10 oC / min) 170 oC. TS = 16.5 min; TR = 16.9 min.
2-hexanol (2.19) Conversion (100%) and ee (<5%) were determined using a Chiralsil
DEX-CB column (25m x 250 μm x 0.25 μm) Tinlet = Tdet = 250 oC; Tstart = 80 oC (12 min)
– (10 oC / min) 170 oC. TS = 5.3 min; TR = 7.5 min.
Cyclohexenol (2.20)[35] Conversion (85%) and ee (<5%) were determined using a
Chiralsil DEX-CB column (25m x 250 μm x 0.25 μm) Tinlet = Tdet = 250 oC; Tstart = 110
oC (12 min) – (1 oC / min) 170 oC. TS = 28.6 min; TR = 29.1 min.
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The use of SPO Ligands in the




In this chapter the use of an SPO ligand in the ruthenium and iridium catalyzed
asymmetric hydrogenation of 2-methyl acetophenone is described. The best results were
obtained when iridium was used as the metal in the presence of KOtBu, pyridine and the
diamine DPEN. Under those conditions 91% conversion and 30 % ee were obtained. In
the iridium/phosphoramidite based asymmetric hydrogenation of 2-methyl acetophenone
85 % conversion and 68 % ee were obtained when the hydrogenation was carried out in




3.1.1 Secondary Phosphine Oxides
Secondary phosphine oxides (SPO’s) are an interesting new class of ligands.[1-4]
They are easily synthesized in racemic form by adding a Grignard reagent to a
RPCl2 substrate followed by acidic aqueous work-up.[5] The obtained substances
are air and moisture stable for long periods of time.
Figure 1: Racemic SPO’s can be synthesized via a simple Grignard addition followed
by aqueous acidic work-up.
The free SPO’s exits in an equilibrium in which the phosphorus atom can easily
switch between a pentavalent configuration (L1{V)) and a trivalent one (L1(III)) as
depicted in Figure 2. Under ambient conditions this equilibrium lies far on the
side of the pentavalent configuration. For catalysis, the trivalent configuration is
however the most interesting one. When the SPO is in its trivalent configuration
it has a free electron pair which can coordinate to a transition metal via σ-
donation. This makes them an interesting class of ligand for transition metal
catalysis.
Figure 2: The two existing forms of SPO ligands (P(V) & P(III)) and its transition metal
binding mode.
A major drawback of using SPO’s in asymmetric catalysis, however, is the fact
that there are no general methods available for synthesizing them in an
asymmetric fashion. The main method for obtaining SPO’s in enantiomerically
pure form is by performing preparative chiral HPLC separations of a racemic
mixture. This is, of course, not ideal since only small amounts of product can be
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obtained that way. Also, the SPO ligands are not very soluble so only very dilute
mixtures can be used in the resolution.
Another way of separating the two enantiomers is by selective crystallization. In
this technique a resolving agent is added to a racemic mixture of the desired
product. The resolving agent is chosen in such a way that only one of the two
enantiomers of the product interacts with the resolving agent and forms a
complex which crystallizes from the solution. Mostly the interactions between
the resolving agents and the desired product are based on salt formation or
hydrogen bonding. In 1999 Drabowicz et al.[6] found that they could separate a
racemic mixture of t-butylphenylphosphine oxide via a resolution using (R)-bis-
β-naphthol (3.1) or (S)-mandelic acid (3.2) as complexing agents. They were
able to get a single enantiomer in excellent optical purity, however, the overall
yield of these resolutions was low (28-52 %). Despite the low yield it seemed to
be a good alternative for an earlier method[7;8] which involved conversion of the
SPO into the corresponding thiophosphoric acid, followed by resolution with -
methylbenzylamine and finally desulfurization which is a lengthy and time
consuming method. The method turned out, however, to be irreproducible.
Figure 3: Resolving agents (R)-bis-β-naphthol, (S)-mandelic acid and (S,S)-DBTA used
for the separation SPO enantiomers.[6;9]
In 2009 Holt et al.[9] found a method to separate the two enantiomers of tert-
butylphenylphosphine oxide by selective crystallization using the resolving
agent DBTA (Dibenzoyl tartaric acid, 3.3). They were able to obtain high yields
and crystallize large batches of racemic ligand into single enantiomers with over
99% ee. This easy way of separating the two enantiomers makes them even
more interesting as ligands in transition metal catalysis.
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3.1.2 Previous use of SPO ligands in asymmetric catalysis
SPO ligands have been used successfully in several transition metal catalyzed
reactions like hydroformylations,[10] the Pd catalyzed Stille coupling,[11] the
Suzuki coupling,[12] the Ni catalyzed Grignard addition,[13] the Ru catalyzed
arylation[14] and others[4].
Of course, SPO ligands have not only been used in non-asymmetric
transformations. Various iridium and rhodium complexes of SPO ligands have
been prepared and applied in several asymmetric hydrogenation reactions. In the
iridium-catalyzed hydrogenation of imines[5] it was shown that the SPO ligand
L1 in combination with one equivalent of pyridine leads to full conversions and
ee’s up to 83% (Figure 4).
N
[Ir(COD)Cl]2/ SPO/ Pyridine






ee up to 83%
Figure 4: Iridium catalyzed asymmetric hydrogenation of imines using an SPO ligand.[5]
In the rhodium-catalyzed hydrogenation of several β-dehydroamino acids,
itaconates, and carbamates the SPO ligands also proved to be suitable as chiral
P-ligands.[15;16] Besides being used in asymmetric hydrogenations, Dai et al.
have shown that SPO ligands can be used in palladium catalyzed allylic
substitution reactions.[17] They were able to reach up to 80% ee in the allylic
alkylation of 1,3-diphenyl prop-2-enyl acetate and dimethyl malonate as shown
in Figure 5.
Figure 5: Pd-catalyzed allylic alkylation reaction using an SPO as chiral ligand as
performed by Dai et al..[17]
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3.1.3 Previously obtained results obtained in Ir catalyzed
hydrogenations of ketones
In the field of asymmetric hydrogenation, iridium is one of the preferred
transition metals.[18] In particular, it is the metal of choice for imine
hydrogenation.[19] In the field of ketone hydrogenation, however, iridium plays a
less important role. Nevertheless, a few examples are known in which the
iridium-catalyzed hydrogenation of ketones gives good results.
Le Roux et al.[20] obtained very good results when using a ferrocenyl based P,S-
ligand. They were able to hydrogenate para-substituted acetophenones with
selectivities up to 99 %.
Figure 6: Iridium catalyzed asymmetric hydrogenation of acetophenones as described
by Le Roux et al.[20].
Using Binap as a ligand in combination with bis(o-
dimethylaminophenyl)phenylphosphine (3.4) Zhang et al.[21] were able to reach
up to 84% ee in the asymmetric hydrogenation of acetophenones.
Figure 7: Bis(o-dimethylaminophenyl) phenylphosphine (3.4) as used by Zhang et al.[21]
and the best performing diamine ligand 3.5 as used by the group of Wills[22] in the Ir(III)
catalyzed asymmetric hydrogenation of acetophenones.
In 2009 the group of Wills reported the iridium(III) catalyzed asymmetric
hydrogenation of acetophenones using chiral diamines as a ligand.[22] They were
able to hydrogenate several acetophenones; reaching full conversion and
Chapter 3
78
moderate ee’s up to 85%. This was an improvement of the results of Ferrand et
al. who, in 2002, did not surpass 68% ee in the hydrogenation of acetophenones
using a similar diamine-Ir(I) catalyst.[23]
3.2 Goal
Monodentate phosphoramidites work very well in the asymmetric hydrogenation
of acetophenones, as has been shown in chapter 2 of this thesis. We decided to
investigate whether the use of an SPO ligand would also result in an active
catalyst as has been the case in other hydrogenations.[5;15;16] As a starting point
we took the ruthenium based catalyst as described in chapter two and simply
replaced the phosphoramidite ligands with the SPO ligand. Since it is known that
SPO ligands can perform very well as ligands for iridium we also investigated
the performance of such a catalyst in the asymmetric hydrogenation of
acetophenone.
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3.3 Results
Tert-butyl(phenyl)phosphane oxide (L1) was synthesized in our labs and
separated in its enantiomers by J. Holt via selective crystallization using (-)-3.3.[9]
The ligand was liberated from its complexing salt by washing with an aqueous
solution of 5% NaHCO3 and extracting it with Et2O resulting in the free ligand
as a white powder. The free ligand was used in the hydrogenations described in
this chapter.
3.3.1 SPO ligands in a ruthenium catalyst
To test the versatility of the SPO ligand L1 in the aryl ketone hydrogenation we
decided to replace the phosphoramidite ligands in the catalyst used in chapter 2
by SPO ligands. The catalysts used in the reactions were all formed in situ, in
accordance with the methods described in Jiang et al.[5]
The results of these ruthenium/L1 catalyzed hydrogenations are depicted in
Table 1.
From the experiments it became clear that addition of a base is necessary to
activate the complex. Without a base (entries 1, 4 and 8) present in the reaction
mixture no reaction takes place. Also it is obvious that the presence of the
diamine is crucial in order to get any enantioselectivity. Without diamine present
(entries 1, 8 and 9) only racemic product was found, if any. The best results were
obtained when both a base and diamine were used. Using only L1 as phosphorus
ligand in the reaction (entries 1-4) did not lead to very good results. After 24
hours only 20% conversion was observed and the product had a negligible ee
(entry 2). Pre-forming the catalyst, as was done for the hydrogenations described
in chapter 2, did give some improvement (entry 3). The conversion after 24
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hours went up to 52% although unfortunately the ee was still very poor reaching
a value of only 14%.
Table 1: Results obtained in the ruthenium-catalyzed asymmetric hydrogenation of 3.6
using SPO ligand L1.
Unless stated otherwise reactions were carried out in the Endeavor with (S)-L1,
[RuCl2(cymene)]2 and (S,S)-DPEN. 2 mmol 3.6 (4/1/2/800) in 4 mL iPrOH. 25 bar H2 at
30 oC for 24 h. a) catalyst was pre-prepared via the M:L = 1:2 method as described in
chapter 2. b) L1/”extra ligand/DPEN/”Ru” = 2/2/2/1 c) L1/”extra ligand”/DPEN/”Ru” =
4/4/0/1. d) Conversions and ee’s were determined via chiral GC using a Chiralsil Dex-








1 - no no 0 nd
2 - yes KOtBu 20 6
3a - yes KOtBu 52 14
4a - yes no 0 nd
5 L2b yes KOtBu 60 rac (0)
6 L2b yes KOtBu 65 7
7 L2b yes KOtBu 56 9
8 (S)-L3c no no 0 nd
9 (S)- L3c no KOtBu 14 rac (1)
10 (S)- L3b yes KOtBu 76 17
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As described in previous chapters of this thesis (see chapters 1 and 2),
employing a mixed ligand approach can sometimes lead to a great enhancement
of the activity and selectivity of the used catalyst. Adding other ligands, like
PPh3 (L2) or PipPhos (L3) (entries 6 & 10) to the reaction mixture in this case
gave some improvement. When L2 was added (entry 6) the conversion went up
to 65% but the ee went down again to a mere 7%. When the chiral
phosphoramidite ligand L3 was added (entry 10) the conversion increased to
76% and an ee of 17% was found. Although this is an improvement compared to
the cases in which only SPO ligands are used, the enantioselectivity of the
hydrogenation is still very poor.
3.3.2 SPO ligands in an iridium catalyst
The results of the ruthenium catalyzed hydrogenation of 3.6 using ligand L1 did
not give satisfactory results. From the work of X.-B. Jiang it is known that L1
bound to iridium(I) can act as a hydrogenation catalyst for several olefins and
imines.[5;15;16]
We decided to see if a change of metal from ruthenium to iridium would lead to
a better acetophenone hydrogenation catalyst. The results of this screening can
be found in Table 2.
As can be seen in Table 2 the results of the Ir/SPO catalyzed hydrogenation are
slightly better than those for the Ru/SPO catalyzed hydrogenations. The best
results were obtained when the reaction was performed in iPrOH or toluene in
the presence of diamine and base (entries 4 and 6). In these cases over 90%
conversion and up to 30% ee was obtained.
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1 L2a yes KOtBu iPrOH 68 15
2 L2b no KOtBu iPrOH 15 11













7d L2 yes KOtBu iPrOH 100 8
8 (S)-L3b no KOtBu iPrOH 7 -2
9 (S)-L3b no - iPrOH 30 7
10 (S)-L3a yes KOtBu iPrOH 100 7
Unless stated otherwise all reactions were carried out in the Endeavor with 2 mmol 3.6,
[Ir(COD)Cl]2, (S)-L1, (S,S)-DPEN, KOtBu and pyridine (800/1/4/2/8/2) in 4 mL total
reaction volume, 25 bar H2 at 30 oC for 24 h. a) Ir/L1/”extra ligand”/DPEN becomes
1/2/2/2; b) Ir/L1/”extra ligand”/DPEN becomes 1/4/4/0 c) ee’s and conversions were
determined via chiral GC using a Chiralsil Dex-CB column (110 oC isotherm); d) No
SPO ligand was added so Ir/L1/”extra ligand”/DPEN (1/0/4/2).
All attempts to improve this result unfortunately failed. When L3 was used as an
additional ligand (entry 10), full conversion was reached but almost all
enantioselectivity was lost in that case. Adding an achiral phosphine L2 (entries
1 and 2) affected both conversion and ee in a negative way. One interesting
observation that was made was a huge improvement in conversion when an
equivalent of pyridine was added to the reaction, however, the selectivity, again,
was not affected by this additive.
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So despite the fact that the Ir/SPO based catalyst gives better results compared to
the Ru/SPO based catalyst, the results are still nowhere near the results that were
obtained when the phosphoramidite ligands were used.
3.3.3 Phosphoramidite ligands in an iridium catalyst
Since use of the SPO ligand L1 did not lead to good results in the hydrogenation
of acetophenones we decided to try the combination of phosphoramidites with
iridium.
Previously it was found that in the iridium catalyzed asymmetric hydrogenation
of enamides, it was possible to obtain good conversions and, more important,
very good selectivities when only one phosphoramidite ligand per metal center
was used.[24]
The use of phosphoramidite ligands in the iridium catalyzed hydrogenation of
3.6 gave better results compared to the catalyst in which SPO ligands were used
but did not give the improvement we hoped for. We did, however, observe some
striking differences in comparison to the iridium catalyzed hydrogenations in
which the SPO ligand was used. What was not different was the need for the
presence of a chiral diamine in order to obtain good ee’s (entries 3, 4), also here
it was observed that the use of a diamine in the reaction is necessary to obtain
reasonable ee’s (>15 %).
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1 L4 DPEN 2 1 28 68
2 L4 DPEN 1 0.5 85 68
3 L4 - 1 0 41 15
4 L4 - 2 0 12 9
5 L4 DPEN 1.5 0.5 18 34
6 - DPEN 0 0.5 100 25
7 - DPEN 0 1 95 31
8 - DPEN 0 2 65 21
9 L4 DPEN 2 2 40 31
10a L4 DPEN 1 0.5 33 20
11 L4 DACH 1 0.5 25 25
12a L4 DACH 1 0.5 53 18
13 L5 - 1 0 0 Nd
14 L6 - 1 0 100 5
15 L5 - 1 0b 0 Nd
16 L6 - 1 0b 100 1
Reactions were carried out in the Endeavor with 2 mmol 3.6 and 0.125 mol% Ir with
various amounts of phosphoramidite and diamine in 4 mL iPrOH. 25 bar H2 at 30 oC for
24 h. In all cases the diamine had the same absolute configuration as the
phosphoramidite ligand. The predominant configuration in the product was the opposite
from the ligand and diamine i.e. R-ligand and R,R-diamine gave S-product. a) KOtBu
was added to the reaction mixture b) 1 equivalent of pyridine was added per metal
centre. c) conversions and ee’s were determined via chiral GC using a Chiralsil Dex-CB
column (110 oC isotherm).















One of the most striking differences was the fact that no base was needed to get
the reaction to proceed. On the contrary even, when base was added to the
reaction mixture, the catalyst performed actually worse, compared to the base
free one (entries 2, 11 and 10, 12). When DPEN was used as the diamine (entries
2 and 10) both conversion and ee dropped dramatically when base was added.
When DACH was used as diamine, addition of base raised the conversion but
the ee went down to a mere 18 %.
Another difference between the SPO and phosphoramidite catalysts is the fact
that phosphoramidite ligands give the best results when only one
phosphoramidite ligand per metal center is used. Also the number of diamine
molecules per metal center has a lower optimum, at one diamine per two iridium
centers. Noteworthy was the fact that the phosphoramidite ligands that
previously were used successfully in an iridium catalyzed asymmetric
hydrogenation with only one ligand per metal center (L5 & L6) did not lead to
any enantioselectivity.[24] Use of L5 did not lead to any conversion whereas use
of L6 did result in full conversion but no selectivity whatsoever was observed.
When L4 was used in combination with 0.5 equivalents of DPEN per iridium
dimer the best results were obtained leading to 85% conversion with an ee of
68%. This is a reasonably result for an iridium catalyzed hydrogenation of
ketones,[20-23] but for the hydrogenation of ketones with phosphoramidite ligands
the use of ruthenium is preferred. However, being able to perform the reaction
without a base present, might make the catalyst interesting for ketones which





The results discussed in this chapter show that, despite success in other types of
hydrogenations, SPO ligand L1 is not suitable for the use in the ruthenium or
iridium catalyzed asymmetric hydrogenations of ketones. Although we were
able to reach full conversion in the case where PipPhos was used as an
additional ligand in the reaction, in none of the reactions ee’s were obtained over
30%. Perhaps a screening of other SPO ligands might come up with a better
suited ligand for this type of hydrogenation.
When, instead of an SPO ligand, a phosphoramidite ligand was used in the
iridium catalyzed hydrogenation of 3.6, somewhat better results were obtained.
A conversion of 85% and an ee of 68% was a promising result but these results
compare very poorly with the ones obtained with the Ru/phosphoramidite
catalyst described in chapter 2. Noteworthy is the fact that in the
Ir/phosphoramidite catalyst the use of only one bulky phosphoramidite ligand
per metal center in the end gave the best result. Also no base was needed in this
case in order to activate the catalyst. This in contrast to the catalysts used in
Chapter 2 where a second phosphoramidite is needed and also the reaction does




For general experimental remarks see Chapter 2. The SPO ligand L1 was synthesized by
E.P. Schudde in our labs and separated by J. Holt into the L1-(-)-3.3 complex with an
ee >98%. L2 was purchased from Aldrich, L3 and L4 were prepared as described in
Chapter 2, L5 and L6 were kindly provided by N. Mršić. [IrCl(COD)]2 was purchased
from Strem, used as received and stored in the glove box.
Liberation of tert-butyl(phenyl)phosphine oxide (L1) from its resolving agent.[15]
L1-(-)-3.3 complex, 595 mg (1.1 mmol), was washed with 5% NaHCO3 for 15 minutes,
after which the free (S)-L1 ligand was extracted from the aqueous solution using diethyl
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ether. After extraction the organic layer was dried over NaSO4 and the solvent was
removed in vacuo resulting in 145 mg (0.80 mmol, 73%) of free ligand as a white
powder. Mp: 74-76 °C. 1H NMR (400 MHz, CDCl3) δ (ppm) 7.38-7.67 (m, 5H), 6.98 (d,
1H, 1JH-P = 454.6 Hz), 1.08 (d, 9H, 3JH-P = 16.6 Hz). 31P NMR (161 MHz, CDCl3) δ
(ppm) 47.3 (s). [] = –32.5 (0.91)
General procedure for the ruthenium catalyzed asymmetric hydrogenation of o-
methyl acetophenone
0.31 mg (0.5 μmol) [RuCl2(cymene)]2, 0.36 mg (2.0 μmol) (S)-L1 and 0.21 mg (1 μmol)
(S,S)-DPEN are weighted and together with 0.26 mL (2 mmol) 3.6 dissolved in 3.7 mL
iPrOH till a final volume of 4 mL. As last component the base (KOtBu) is added as a 1
M solution in iPrOH. The solution is put in the Endeavor where hydrogenation takes
place at 30o C, 25 bar H2 and stirring at 750 rpm for 24 hours. After 24 hours the
pressure was released and from the reaction mixture a small sample was run over a short
silica plug and made into a sample for the GC. Conversion and ee were determined using
a Chiralsil DEX-CB column (25m x 250 μm x 0.25 μm) with an isothermal program at
110 oC. TS = 13.6 min TR = 12.0 min
General procedure for the iridium catalyzed asymmetric hydrogenation of o-
methyl acetophenone
0.34 mg (0.5 μmol) [Ir(COD)Cl]2, 0.36 mg (2.0 μmol) (S)-L1 and 0.21 mg (1 μmol)
(S,S)-DPEN were weighed and together with 0.26 mL (2 mmol) 3.6 dissolved in 3.7 mL
iPrOH till a final volume of 4 mL. As last component the base (KOtBu) was added as a
1M solution in iPrOH. The solution was placed in the Endeavor where hydrogenation
took place at 30o C, 25 bar H2 and stirring at 750 rpm for 24 hours. After 24 h the
pressure was released and from the reaction mixture a small sample was run over a short
silica plug and made into a sample for the GC. Conversion and ee were determined using
a Chiralsil DEX-CB column (25m x 250 μm x 0.25 μm) with an isothermal program at
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In this chapter the ruthenium catalyzed enantioselective hydrogenation of α- and β-
ketoesters using phosphoramidite ligands is discussed. It was shown that the
hydrogenation of α-ketoesters proceeds to furnish essentially racemic product with such
a catalytic system. However, the hydrogenation of several β-ketoesters was achieved





The asymmetric hydrogenation of ketoesters has been a topic of interest for
many years. Since the discovery of the Ru-Binap catalyst by the group of
Noyori[1;2], for the reduction of β-ketoesters in an enantioselective manner by
means of hydrogenation, a lot of work has been done in this field. The groups of
Genêt,[3] Weissensteiner,[4] Imamoto,[5] Knochel,[6] Zhang,[7] Reetz[8] and many
others[9;10] successfully developed new ligands for this reaction. All these groups,
however, designed synthetically laborious chiral bidentate phosphorus ligands,
as shown in Figure 1, to be used in this transformation.
Figure 1: A selection of bidentate phosphorus ligands which have been used
successfully in the asymmetric hydrogenation of β-ketoesters.
All previously mentioned ligands are able to induce excellent ee’s and
conversions in the asymmetric hydrogenations of several β-ketoesters. Despite
numerous examples of the use of monodentate ligands in other types of
asymmetric hydrogenations, such as the reduction of various olefins[11-14],
imines[15;16] and acetophenone type ketones[17;18] up to date only one study has
been reported on the asymmetric hydrogenations of β-ketoesters. The group of
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Beller tested several phosphepine ligands (Figure 2), with different alkyl and
aryl substituents on the phosphorus atom. They were able to reach full
conversion and up to 95% ee for several β-ketoesters when the p-anisyl
substituent was used.[19;20]
Figure 2: Monodentate phosphepine ligands as used by the group of Beller in the
asymmetric hydrogenation of β-ketoesters
4.1.1 Use of β-ketoester hydrogenation in synthesis
The hydroxy-ester products of the asymmetric hydrogenation of β-ketoesters can
be used in the synthesis of a wide variety of natural and biologically active
compounds. A few examples of compounds that were synthesized, involving an
asymmetric hydrogenation of a β-ketoester as a key step are given in Figure 3.




A class of compounds that is very well accessible through β-ketoester
hydrogenation is the class of statins.[21-23] But also biologically active and widely
used compounds like the class of anti-biotics Carbapenem,[24] Fluoxetin (4.3),
the active ingredient of Prozac® and Duloxetin (4.4), another anti-depressive,
can have their stereogenic center introduced by means of hydrogenation of a β-
ketoester.[3] The final example of a natural product given in Figure 3 which is
accessible through the hydrogenation of a β-ketoester is corynomycolic acid (4.5)
which is a fatty acid from the cell walls of Corynebacterium sp. and shows
significant biological activity.[3]
Figure 4: Nonactin, with in the encircled the the part of the molecule where the chiral
center is introduced via an asymmetric hydrogenation of ethyl acetoacetate.[25]
Even in the synthesis of the complex macrocycle nonactin (Figure 4) the starting
point was the hydrogenation of a β-ketoester as was shown by Coutable et al..[25]
4.1.2 Mechanism of the hydrogenation of β-ketoesters
The catalytic cycle of the hydrogenation of β-ketoesters[26;27] (Figure 5) starts off
from the ruthenium mono hydride complex (I), which is formed with the
dichloride precursor by heterolytic splitting of a hydrogen molecule. The
substrate is bound to the ruthenium in a bidentate fashion via both carbonyls (II),
replacing one or more solvent molecules. The binding of the ester carbonyl
group is vital for the reaction to proceed.
To make sure the substrate stays in close proximity of the Ru-center long enough
for the reaction to take place it needs an anchoring group in addition to the
carbonyl that is to be reduced. The carbonyl group of the ester acts as such an
anchoring group ensuring the reaction is able to proceed.
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Figure 5: Mechanism of the β-ketoester hydrogenation.
After the hydride transfer from the Ru-center to the keto carbonyl, protonation
with a proton from the solution completes the reduction (III) and the product is
released from the metal where one or more solvent molecules take its place (IV).
Another heterolytic splitting of a hydrogen molecule completes the cycle by
forming again the ruthenium mono hydride complex (I).[28]
4.1.3 Introduction into α-ketoester hydrogenation
In comparison with the β-ketoesters a lot less examples are known, in which
asymmetric hydrogenation is used for the reduction of α-ketoesters, with good
results.[29] There are a few examples by Boaz et al.[30] who used the ferrocenyl
ligand 4.9 in the rhodium catalyzed hydrogenation of pyruvate and obtained up
to 88% ee and up to 97% ee when 4.8 was used as substrate. Mortreux et al. used
the phosphinite 4.6[31] and the chromium complexed aminophosphine 4.7[32;33] in
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the rhodium catalyzed asymmetric hydrogenation of pyruvate in 86% and 89%
respectively. When 4.7 was used in the rhodium catalyzed hydrogenation of 4.8
ee’s up to 99% were obtained. Mashima et al.[34] used a cationic ruthenium-
binap catalyst and were able to reach up to 93% ee in the α-ketoester
hydrogenation.
Figure 6: Ligands used in the alpha-ketoester hydrogenation.
But for the best results in this type of transformation mostly a biochemical route
is followed using whole cells[35;36] or isolated enzymes.[37;38]
In 2005, Sun et al. described the positive influence of the addition of
CeCl3.7H2O on the outcome of the hydrogenation of α-ketoesters. A significant
increase in ee was observed (in some cases of even 36 percent points going from
40 to 76% ee) when using this salt as an additive in the reaction. They contribute
this to a coordination of the ester to the cerium as shown in Figure 7. This
coordination makes that the ester has a more constrained conformation leading
to the increase in ee.[39;40]
Figure 7: Complexes formed during hydrogenation of α-ketoesters in the presence of a
cerium salt (X = Cl, H2O or solvent).
Also the hydrogenation of α-ketoesters has been used in the synthesis of natural
compounds. In 2009 Tone et al.[41] reported the first synthesis of
Gymnangiamide. This total synthesis starts with the asymmetric hydrogenation
of an α-ketoester. By synthesizing the molecule, the authors en passant
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disproved the absolute stereochemistry that was proposed earlier for the C-34
center of the serine residue by Gustafson et al..[42] Gustafson proposed that this
C-34 residue came from a L-serine giving the 34S stereoisomer. Tone, however,
showed that the molecule as the 34R stereoisomer, coming from D-serine,
displayed a biological activity closer to the natural product than when the 34S
isomer was tested.
Figure 8: Structure of Gymnangiamide with the C-34R stereogenic center obtained by
asymmetric hydrogenation of an α-ketoester.
In the synthesis of Amphidinolide Y, which is an interesting cytotoxic
compound isolated from the marine species Amphidinium sp., the ruthenium-
binap catalyzed asymmetric hydrogenation of an α-ketoester is used as one of
the key steps in the synthesis.[43]
Figure 9: Amphidinolide X and Y; utilizing an asymmetric hydrogenation of an α-




With the good results obtained in the asymmetric hydrogenation of aromatic
ketones using phosphoramidite ligands in hand, we decided to focus our
attention on a different type of ketones. In DSM some attempts had been made
in the asymmetric hydrogenation of α- and β-ketoesters using phosphoramidite
ligands. The results there obtained were not very good. In no case a significant
ee was found and conversions were mostly poor. But with the experience of the
acetophenone type ketones in hand we decided to have another look at these
substrate classes. Using the ruthenium type catalyst as described by Noyori[1]
replacing the bidentate binap ligand by two monodentate phosphoramidites.
In this chapter the development of an effective ruthenium catalyst containing
monodentate phosphoramidite ligands for the asymmetric hydrogenation of α-
and β-ketoester will be discussed.
4.3 Results
4.3.1 β -Ketoester results
At DSM the best result in the asymmetric hydrogenation of β-ketoesters was
obtained with a Rh-based catalyst in combination with a phosphoramidite ligand
(up to a maximum of 41% ee). The reactions with the ruthenium type catalysts
were reported to have a lot of side products, nevertheless we decided, based on
the good results reported in the literature, to start with a ruthenium based catalyst.
4.3.1.1 The complex
The catalysts for all the reactions as described in this chapter were synthesized
starting from the ruthenium precursor [RuCl2(cymene)]2. To this precursor four
equivalents of the appropriate monodentate, or two equivalents of a bidentate
ligand were added in DMF. This mixture was heated at 90 oC in a Schlenk tube
under nitrogen for two hours. In order to obtain the catalyst the DMF was
Enantioselective Hydrogenation of α- and β-Ketoesters
using Monodentate Phosphoramidites Ligands
99
evaporated in vacuo, the residue was immediately used, without purification, in
a hydrogenation reaction.
Figure 10: Schematic representation of complex formation when using monodentate
phosphoramidite ligands.
The 31P-NMR of the complex obtained with L9 showed only one very broad
peak between 160-150 ppm. Since we knew from the attempts to isolate and
indentify the complex that was formed for the acetophenone hydrogenation (see
chapter 2), that the phosphoramidite ligands can be easily removed from the
ruthenium when in solution, we did not pursue the purification any further.
To investigate the influence of more or less ligand present in the reaction
mixture we decided to vary the amount of ligand in the reaction.
Table 1: Ligand : Metal ratio screening.





All reactions were done in MeOH on a 2 mmol scale in a total volume of 4 mL at 70 oC
and 70 bar H2 for 24h. Substrate/Ru/L9: 400/1/2. The catalysts were prepared in the same
way described in 4.3.1.1. a) Conversions and ee’s were determined via chiral GC.
As can be seen in Table 1, the best results are obtained when using a 2:1 ligand
to metal ratio. Going below that ratio the reaction still went to full conversion
but with a much lower ee. Adding more ligands per metal center resulted in a
slower reaction and also in a somewhat decreased ee. This indicates that two
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ligands per metal center are needed for a good enantiomeric excess; increasing
this ratio however leads to overcrowding at the metal which leads to a much
slower and less selective reaction.
4.3.1.2 Screening of reaction conditions
For the screenings towards the most optimal reaction conditions we used 0.25
mol% of the complexes described above in reactions on 2 mmol scale. The
screenings started with a small solvent screening in the hydrogenation of methyl
acetoacetate (4.10a) (Table 2) that showed that the use of an alcohol was needed
to reach good conversions and ee’s. DCM as a solvent also gave a good result in
terms of ee, but the reaction did not go to completion in the 24 hours it was
allowed to run. For this reason, and the fact that an alcohol would give us a
broader temperature range to work at because of their higher boiling points, we
decided to use an alcoholic solvent in all further experiments. Further screening
showed that the optimal pressure and temperature for this reaction was 70 bars
of hydrogen pressure at a temperature of 70 oC. Using DiMePip (L4, see ligands
under Table 3) under these conditions we were able to reach full conversion and
95% ee in the hydrogenation of methyl acetoacetate towards the corresponding
β-hydroxy ester within 24 hours. Changing the solvent from MeOH to toluene or
DCM did not result in a further improvement of the results. In toluene no
reaction took place at all whereas in DCM the reaction resulted in more or less
the same ee as when the reaction was done in MeOH but the conversion was not
complete after 24 hours.
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Table 2: Condition screening.
Reactions were done on a 2 mmol scale in a total reaction volume of 4 mL in a small vial,
containing a stir bar, which was placed inside an autoclave, for 24 h.. Substrate/Ru/L4:
400/1/2. The catalysts were prepared in the same way described in 4.3.1.1. a) Ee’s where
determined via chiral-GC on a GTA-column.
4.3.1.3 Ligand screening
After determining the optimal reaction conditions we set out to find the best
performing phosphoramidite ligand for this reaction. This screening of ligands
(Table 3) showed that the presence of a group on the 3 and 3’ position of the
binol backbone had a positive influence on the ee of the product (L4, L5, L6 and
L9 vs. L2 and L8). Since it doesn’t seem to matter what kind of substituent is
present at this position it suggests to us that the increase in ee can purely be
attributed to the increase in bulkiness of the ligand. Also switching from normal
PipPhos (L2) to the partially saturated, and sterically bulkier, 8H-PipPhos (L8)
gave a drastic increase in ee going from 51% to 74%.
Since introduction of methyl groups at the 3,3’ positions of the binol-backbone
also led to a much higher ee we decided to combine the two backbone variations
and examine 8H-DiMePip (L9) as a ligand. This proved to be the key to success
in this case, as the catalyst based on this ligand led to full conversion in 24 hours
and 99% ee in the hydrogenation of 4.10a.
Solvent P (bar) T (oC) Conversion (%) Eea (%)
1 MeOH 60 50 90 95
2 MeOH 70 70 100 95
3 MeOH 80 70 100 95
4 Toluene 70 70 0 -
5 DCM 70 70 65 94
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Table 3: Ligand screening in the asymmetric hydrogenation of β-ketoesters.
All reactions were done in MeOH on a 2 mmol scale in a total volume of 4 mL at 70 oC
and 70 bar H2 for 24h. Substrate/Ru/L: 400/1/2. The catalysts were prepared in the same
way described in 4.3.1.1 a) ee’s were determined via chiral GC b) Substrate/Ru/L:
400/1/1.
Ligand Conversion (%) Eea (%)
1 (S)-L1 98 45 (R)
2 (S)-L2 94 51 (R)
3 (S)-L3 92 73 (R)
4 (R)-L4 100 95 (S)
5 (S)-L5 95 97 (R)
6 (S)-L6 92 97 (R)
7 (S)-L7b 98 74 (R)
8 (S)-L8 86 74 (R)
9 (R)-L9 100 99 (S)
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From these screening reactions it became clear that the best results in the
hydrogenations of methyl acetoacetate (4.10a) are obtained when ligand L9 is
used as a ligand to a ruthenium based catalyst. When the reaction was run for 24
hours at 70 bar of hydrogen pressure and at 70 oC we were able to obtain the
product, methyl 3-hydroxybutanoate (4.11a), in full conversion and up to 99%
ee.
4.3.1.4 Substrate scope
Having found the optimal conditions and ligand (L9) for this hydrogenation we
started the investigation towards the substrate scope for the reaction (Table 4).
The performance of the catalyst showed good tolerance towards varying the
alkyl groups in both the ester part of the substrate (4.10a, 4.10b) as well as in
the 4-position (4.10a, 4.10c-e). Although switching to a more bulky substrate
like 4.10d gave somewhat lower conversion and ee (89 and 91%, respectively)
still the results were good. Also a few aryl β-ketoesters were tested (4.10g-k)
showing excellent conversions and high ee’s. Only the 3-(4-pyridyl) (4.10i) and
the 3-chloro (4.10f) substituted substrates showed no or significantly lower
conversions and ee. The lack of conversion that was seen with the pyridyl
substrate was attributed to a co-coordination of the pyridine ring to the catalyst.
This extra coordination to the catalyst could have made it impossible for the
substrate to be hydrogenated or for the product to be easily released from the
complex, blocking access to the complex for further substrate molecules.
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Table 4: Substrate scope of the β-ketoester hydrogenation.
Substrate R1 R2 Conversion (%) Eea (%)
1 4.10a Me Me 100 99 (S)
2 4.10b Me Et 100 98 (S)
3 4.10c n-Pr Et 100 97 (S)
4 4.10d i-Pr Et 89 91 (S)
5 4.10e Et Me 100 98 (S)
6 4.10f CH2Cl Me 90 44 (R)b
7 4.10g Ph Et 100 96 (R)b
8 4.10h m-Cl-Ph Me 95 94 (R)b
9 4.10i 4-Pyridyl Me 0 Nd
10 4.10k 2-furyl Et 100 85 (R)b
All reactions were done in R2OH on a 2 mmol scale in a total volume of 4 mL at 70 oC
and 70 bar H2 for 24h. Substrate/Ru/L9: 400/1/2. The catalyst was prepared in the same
way described in 4.3.1.1 a) ee’s were determined via chiral GC. b) Change of
configuration due to change in priority of the side groups.
Since compounds containing heterocycles are often of great interest for
pharmacological research[44;45] getting the hydrogenation of compound 4.10i
working may serve as a starting point in the development of new active
compounds.
In an attempt to get the hydrogenation of substrate 4.10i working, the reaction
was repeated using several additives (Table 5). The idea, to prevent coordination
of the pyridyl group to the metal center by protonating the substrate by adding 1
equivalent of sulphuric or acetic acid, proved not to work. Also performing the
reaction in neat acetic acid gave no conversion of the substrate.
Adding coordinating salts like lithium chloride or titanium isopropoxide in
various equivalents also proved not sufficient to get the reaction going.
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Table 5: Additive screening for the hydrogenation of 4.10i.
Additives (wrt 4.6i) conversion
1 - none
2 1.0 equiv. HOAc none
3 HOAc as solvent none
4 1.0 equiv H2SO4 none
5 1.0 equiv LiCl <10%
6 1.5 equiv LiCl <10%
7 2.0 equiv LiCl none
8 0.5 equiv Ti(OiPr)4 none
9 1.0 equiv Ti(OiPr)4 none
10 1.5 equiv Ti(OiPr)4 none
All reactions were performed in MeOH on a 1 mmol scale in a total volume of 2 mL at
70 oC and 70 bar H2 for 24h. Substrate/Ru/L9: 400/1/2. The catalysts were prepared as
described in 4.3.1.1. Conversions were determined via GC.
To get more insight in the reaction we tried to hydrogenate methyl acetoacetate
(4.10a) in the presence of different amounts of 4.10i. As can be seen in Table 6,
adding more of 4.10i with respect to methyl acetoacetate resulted in a lower
conversion of the substrate into the β-hydroxyester all the way to complete
blocking of the conversion when a one to one mixture was used. In none of the
cases the product of the hydrogenation of 4.10i was found.
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Table 6: Inhibition experiment with substrate 4.10i.







All reactions were done in MeOH on a 1 mmol scale in a total volume of 2 mL at 70 oC
and 70 bar H2 for 24h. Substrate/Ru/L9: 400/1/2. 4.10i was added to the reaction vials in
indicated amounts. Conversions were determined via GC.
A structurally equivalent compound (acetyl pyridine 4.12) proved to be an even
more efficient inhibitor of the hydrogenation of methyl acetoacetate as can be
seen in Table 7.
Table 7: Inhibition of the hydrogenation of 4.10a by 4.12.





All reactions were done in MeOH on a 1 mmol scale in a total volume of 2 mL at 70 oC
and 70 bar H2 for 24h. Substrate/Ru/L9: 400/1/2. 4.12 was added to the reaction vials in
indicated amounts. Conversions were determined via GC.
These results suggest that the pyridyl ring in some way inactivates the catalyst in
this reaction completely. These observations would also explain the lack of
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literature data on the reduction of these pyridyl substrates to their β-
hydroxyesters. To the best of our knowledge only one patent describes the
reduction of this type of substrates by means of asymmetric transfer
hydrogenation[46] and one by means of biochemical reduction.[47]
4.3.1.5 Conclusion on the hydrogenation of β-ketoesters
From the results described above it can be concluded that we have developed a
ruthenium based catalyst, containing monodentate phosphoramidite ligands,
which is able to hydrogenate a range of beta-ketoesters in good yields and with
excellent enantioselectivities. The best performing ligand proved to be the partly
saturated and methyl substituted phosphoramidite L9. When used in a 2 :1
ligand to metal ratio the complex can be used with a 0.25 mol% loading at 70 oC
and at 70 bars of hydrogen pressure the reactions are usually complete within 24
hours.
4.3.2 Results of the α –ketoester hydrogenation
In an attempt to find a good system for the asymmetric hydrogenation of α-
ketoesters we tested a few ligands in the hydrogenation of methyl pyruvate
(4.13). The reactions were performed in MeOH while applying 50 bar of
hydrogen pressure at 70 oC for 24 hours. 0.25 mol% Of a ruthenium catalyst was
used in combination with the different ligands. In first instance all reactions were
done without the presence of CeCl3.7H2O.
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Table 8: α-ketoester hydrogenation results.






L1 60 <5 60 <5
L2 75 <5 55 <5
L4 80 <5 60 <5
L10 60 <5 50 <5
All reactions were done in MeOH on a 2 mmol scale in a total volume of 4 mL at room
temperature and 70 bar H2 for 24h. Substrate/Ru/L/CeCl3.H2O: 400/1/2/0 or 5. Ru-
catalyst was prepared as described in 4.3.1.1. a) Conversions and ee’s were determined
via chiral GC.
As in none of the reactions full conversion was reached or any significant ee was
obtained, we decided to add 1.25 mol% cerium salt to the reaction as was
described by Sun et al..[40] Sadly also this proved not to lead to any ee or full
conversions in the reaction.
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4.4 Conclusions
In this chapter it is shown that it is possible to use monodentate
phosphoramidites as ligands in the hydrogenation of β-ketoesters. The
performance of the ligands in this reaction seems to be determined more by the
structure of the backbone than of the amine part of the ligand. Making the
backbone more sterically demanding by placing side groups on the 3 and 3’
position in combination with the saturation of the outer rings of the naphthyl
group, results in ee’s up to 99% with full conversion. These are the best results
obtained in the asymmetric hydrogenation of β-ketoesters when using
monodentate ligands in the catalyst. We showed that this ruthenium catalyst
containing the sterically large phosphoramidite ligand is able to hydrogenate a
range of β-ketoesters and performs best when two phosphoramidite ligands per
ruthenium center are present in the reaction mixture.
The hydrogenation of α-ketoesters with the same type of catalyst led to
incomplete conversions and racemic products. Also the addition of an additive
(CeCl3.7H2O), known to work very well in another case, gave no improvement
of the results.
4.5 Experimental
Starting materials were purchased from Aldrich, Alfa Aesar or Acros and used as
received unless stated otherwise. [RuCl2(cymene)]2 was bought from Strem and used as
received. Substrates 4.10h, 4.10i and (R)-3,3’-dimethyl bis-β-naphthol were kindly
provided by DSM. All solvents were reagent grade and, if necessary, dried and distilled
prior to use. Column chromatography was performed on silica gel (Aldrich 60, 230-400
mesh). TLC was performed on silica gel 60/Kieselguhr F254. 1H and 13C NMR spectra
were recorded on a Varian AMX400 (399.93 MHz for 1H, 100.59 MHz for 13C and
161.9 MHz (1H-decoupled) for 31P). Mass spectra (HRMS) were performed on a Jeol
JMS-600H. HPLC analysis was performed on a Shimadzu HPLC system equipped with
two LC-10AD solvent delivery systems, a DGU-14A degasser, a SIL-10AD vp auto
injector, an SPD-M10A vp diode array detector, a CTO-10A vp column oven, and an
SCL-10A vp system controller using the columns indicated for each compound
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separately. Optical rotations were measured on a Schmidt+ Haensch polarimeter
(Polartronic MH8) with a 10 cm cell (c given in g/100 mL).
Ligands L1,[48] L2-3,[11] L5-6, L7,[49] L8 and L10 were described in literature before and
used from the general phosphoramidite library present in our labs. The preparation of L4




enyl-2,2’-diol (8H-bis-β-naphtol) (1.6 g, 5 mmol) was dissolved
in PCl3 (5 mL) under nitrogen atmosphere. The mixture was
heated under reflux for 16 h, keeping the system under anhydrous
conditions using a CaCl2 tube. Excess of PCl3 was removed by
distillation and the residual solid was subjected to azeotropic
distillation with toluene (3 × 5 mL). The resulting yellow foam was dissolved in toluene
(10 mL). The resulting solution was cooled to 0 oC and Et3N (2 equiv, 10 mmol, 1.4 mL)
was added. This was let to stir for 10 minutes, then piperidine (1.1 equiv, 5.5 mmol, 550
L) in toluene (5 mL) was added dropwise. After stirring overnight, (allowing the
temperature to rise to room temperature) the reaction mixture was diluted with Et2O and
the salts were filtered off. The mixture was concentrated under reduced pressure and the
residue purified by flash chromatography (pentane:Et2O 8:1) to give the pure
phosphoramidite as a white solid still contaminated with some toluene. Stripping with
acetone furnished 1.2 g (2.8 mmol, 56%) of the phosphoramidite as foamy solid. Mp
97.9 - 98.2 °C. 1H-NMR (400 MHz, CDCl3)  (ppm) 6.93 (s, 1H), 6.87 (s, 1H), 2.68-
2.96 (m, 8H), 2.50-2.66 (m, 2H), 2.12-2.38 (m, 8H), 1.63-1.81 (m, 6H), 1.48-1.62 (m,
4H), 1.30-1.46 (m, 4H). 13C-NMR (100 MHz, CDCl3)  (ppm) 147, 147, 135, 135, 133,
132, 130, 130, 129, 128, 127, 126, 44.8, 44.6, 29.1, 29.0, 27.6, 27.4, 27.1, 27.0, 25.0,
23.0, 22.9, 22.7, 22.5, 16.4, 16.2. 31P-NMR (162 MHz, CDCl3)  (ppm) 137.0. HRMS
calcd for C27H34NO2P (M+): 435.2327; found: 435.2295.
General procedure for hydrogenation of β-ketoesters
2.5 μmol of [RuCl2(cymene)]2 and 10 μmol (4 equivalents) phosphoramidite were
dissolved in 1.5 ml DMF. This mixture was stirred while heated for two hours at 90 oC.
After two hours the mixture was let to cool down to room temperature after which the
DMF was removed in vacuo. The residue was dissolved in 4 ml of MeOH in case of a
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substrate in an 8 ml glass vial. The vial was capped with a septum which was pierced by
a hyperdermic needle and put into an autoclave. The autoclave was closed, purged three
times with 5 bar of N2 and three times with 8 bar of H2 before brought up to the working
pressure of 70 bar H2. The autoclave was heated till 70 oC and kept stirring for 24 hours.
After the reaction time the autoclave was allowed to cool down to room temperature
before the hydrogen pressure was carefully released. The solvent was evaporated and of
the remains a small volume was run over a short silica plug in order to make a GC
sample for the determination of conversion and ee.
(S)-Methyl 3-hydroxybutyrate[2] (4.11a) Was obtained as a yellow oil (full conversion,
99% ee), 1H-NMR (200 MHz, CDCl3)  (ppm) 4.28-4.13 (m, 1H), 3.47 (bs, 1H), 3.23 (s,
3H), 2.57-2.36 (m, 2H), 1.23 (d, 3H, J = 6.3 Hz). 13C-NMR (50 MHz, CDCl3)  (ppm)
170.1, 64.2, 42.5, 51.7, 22.4. [α]D = 23.9 (c 0.99, CHCl3). Ee determination was
performed on a GTA-column. Tinlet = Tdet = 250 oC; Tisotherm = 110 oC (15 min) TR = 10.9
min. TS = 11.2 min.
(S)-Ethyl 3-hydroxybutyrate[50] (4.11b) was obtained as a light brown oil (full
conversion, 98% ee). 1H-NMR (200 MHz, CDCl3)  (ppm) 4.28-4.12 (m, 3H), 2.56-2.34
(m, 2H), 1.29-1.13 (m, 6H). 13C-NMR (50 MHz, CDCl3)  (ppm) 172.9, 64.2, 60.6, 42.7,
22.4, 14.2. [α]D = 40.3 (c 0.92, CHCl3). Ee determination was performed on a Chiralsil
DEX CB column Tinlet = Tdet = 250 oC; Tstart = 50 oC (5 min) – (1 oC / min) 170 oC TR
= 23.1 min. TS = 23.5 min.
(S)-Ethyl 3-hydroxyhexanoate[51] (4.11c) was obtained as a yellow oil (full conversion,
97% ee). 1H-NMR (200 MHz, CDCl3)  (ppm) 4.21 (q, 2H, J = 7.1 Hz), 4.08-3.96 (m,
1H), 3.43 (s, 1H), 2.56-2.37 (m, 2H), 1.75-1.36 (m, 4H), 1.28 (t, 3H, J = 7.2 Hz), 0.93 (t,
3H, J = 7.4 Hz). 13C-NMR (50 MHz, CDCl3)  (ppm) 173.1, 67.7, 60.6, 41.3, 38.6, 18.6,
14.2, 13.9. [α]D = 15.3 (c 1.02, CHCl3). Ee determination was performed on a Chiralsil
DEX CB column Tinlet = Tdet = 250 oC; Tstart = 50 oC (5 min) – (1 oC / min) 170 oC TR
= 38.1 min. TS = 40.0 min.
(S)-Ethyl 3-hydroxy 4-methylpentanoate[6] (4.11d) was obtained as a yellow oil (89%
conversion, 91% ee). 1H-NMR (200 MHz, CDCl3)  (ppm) 4.22 (q, 2H, J = 7.0 Hz),
3.98-3.93 (m, 1H), 2.59-2.37 (m, 2H), 1.99-1.86 (m, 1H), 1.28 (t, 3H, J = 7.1 Hz), 0.89
(d, 6H, J = 6.8 Hz). 13C-NMR (50 MHz, CDCl3)  (ppm) 173.6, 73.9, 61.2, 37.9, 35.6,
17.5, 14.1. [α]D = 19.3 (c 0.89, CHCl3). Ee determination was performed on a Chiralsil
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DEX CB column Tinlet = Tdet = 250 oC; Tstart = 50 oC (5 min) – (1 oC / min) 170 oC TR
= 31.2 min. TS = 31.9 min.
(S)-Methyl 3-hydroxypentanoate[52] (4.11e) was obtained as a colorless oil (full
conversion, 98% ee). 1H-NMR (200 MHz, CDCl3)  (ppm) 4.00-3.88 (m, 1H), 3.72 (s,
3H), 3.69, (bs, 1H), 2.55-2.19 (m, 2H), 1.61-1.45 (m, 2H), 0.97 (t, 3H, J = 7.2 Hz). 13C-
NMR (50 MHz, CDCl3)  (ppm) 167.7 69.3, 51.7, 40.6, 29.4, 9.8. [α]D = 35.1 (c 0.92,
CHCl3). Ee determination was performed on a Chiralsil DEX CB column Tinlet = Tdet =
250 oC; Tstart = 50 oC (5 min) – (1 oC / min) 170 oC TR = 17.4 min. TS = 17.9 min.
(R)-Methyl 3-hydroxy 4-chlorobutyrate[53] (4.11f) was obtained as a yellow oil (full
conversion, 44% ee). 1H-NMR (200 MHz, CDCl3)  (ppm) 4.32-4.21 (m, 1H), 3.79-3.60
(m, 6H), 2.72-2.63 (m, 2H). 13C-NMR (50 MHz, CDCl3)  (ppm) 172.1, 67.9, 52.0, 51.8,
38.2. [α]D = 9.6 (c 0.87, CHCl3). Ee determination was performed on a Chiralsil DEX
CB column Tinlet = Tdet = 250 oC; Tstart = 50 oC (5 min) – (1 oC / min) 170 oC TS = 18.6
min. TR = 18.9 min.
(R)-Ethyl 3-hydroxy 3-phenylpropionate[3] (4.11g) was obtained as a yellow oil (full
conversion, 96% ee). 1H-NMR (200 MHz, CDCl3)  (ppm) 7.97-7.35 (m, 5H), 5.14 (dd,
1H, J = 5.0 Hz, J = 7.9 Hz), 4.27 (q, 2H, J = 7.0 Hz), 2.84-2.61 (m, 2H), 1.26 (t, 3H, J =
7.1 Hz). 13C-NMR (50 MHz, CDCl3)  (ppm) 172.4, 142.5, 128.7, 128.5, 128.5, 70.3,
61.5, 43.3, 14.1. [α]D = –50.3 (c 1.08, CHCl3). Ee determination was performed on a
Chiralsil DEX CB column Tinlet = Tdet = 250 oC; Tstart = 50 oC (5 min) – (1 oC / min) 
170 oC TS = 90.1 min. TR = 90.8 min.
(R)-Methyl 3-hydroxy 3-(3-chlorophenyl)-propionate (4.11h) was obtained as a pale
yellow oil (95% conversion, 94% ee). 1H-NMR (200 MHz, CDCl3)  (ppm) 7.83-7.31
(m, 4H), 5.11 (t, 1H, J = 6.3 Hz), 3.76 (s, 3H), 3.73 (s, 1H), 2.74-2.70 (m, 2H). 13C-
NMR (50 MHz, CDCl3)  (ppm) 169.5, 137.4, 135.2, 131.2, 127.9, 126.3, 125.9, 69.6,
52.6, 42.9. [α]D = –49.2 (c 0.79, CHCl3). Ee determination was performed on a Chiralsil
DEX CB column Tinlet = Tdet = 250 oC; Tstart = 50 oC (5 min) – (1 oC / min) 170 oC TS
= 92.5 min. TR = 92.8 min.
(R)-Ethyl 3-hydroxy 3-(2-furyl)-propionate[54] (4.11k) was obtained as a brown oil
(full conversion, 85% ee). 1H-NMR (200 MHz, CDCl3)  (ppm) 7.62 (d, 1H, J = 1.5 Hz),
7.28 (d, 1H, J = 3.1 Hz), 6.57 (dd, 1H, J = 1.7 Hz, J = 3.6 Hz) 4.21 (q, 2H, J = 7.1 Hz),
2.72-2.55 (m, 2H), 1.26 (t, 3H, J = 7.1 Hz) 13C-NMR (50 MHz, CDCl3)  (ppm) 171.9,
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152.0, 142.1, 110.9, 105.9, 65.0, 61.5, 41.5, 14.1. [α]D = 16.3 (c 1.09, CHCl3). Ee
determination was performed on a Chiralsil DEX CB column Tinlet = Tdet = 250 oC; Tstart
= 50 oC (5 min) – (1 oC / min) 170 oC TS = 65.1 min. TR = 65.3 min.
Procedure for hydrogenation of methyl pyruvate (4.13) in the prescense of
CeCl3.7H2O.
2.5 μmol of [RuCl2(cymene)]2 and 10 μmol (4 eq.) phosphoramidite were dissolved in
1.5 ml DMF. This mixture was stirred while heated for two hours at 90 oC. After two
hours the mixture was let to cool down to room temperature after which the DMF was
removed in vacuo. The residue was dissolved in 4 ml of methanol. This solution was
added to 204 mg methyl pyruvate (2 mmol) in an 8 ml glass vial. To this 9.3 mg
CeCl3.7H2O (25 μmol) was added. The vial was capped with a septum which was
pierced by a hypodermic needle and put into an autoclave. The autoclave was closed,
purged three times with 5 bar of N2 and three times with 8 bar of H2 before it was
brought up to the working pressure of 50 bar H2. The autoclave was heated till 70 oC and
kept stirring for 24 hours. After the reaction time the autoclave was allowed to cool
down to room temperature before the hydrogen pressure was carefully released. The
solvent was evaporated and of the remains a small volume was run over a short silica
plug in order to make a GC sample. Conversion and ee of the product were determined
via chiral GC. GTA column, Tinlet = Tdet = 250 oC; Tisotherm = 80 oC (50 min) T1 = 15.2




[1.] M. Kitamura, T. Ohkuma, S. Inoue, N. Sayo, H. Kumobayashi, S.
Akutagawa, T. Ohta, H. Takaya, R. Noyori, J.Am.Chem.Soc. 1988, 110
629-631.
[2.] R. Noyori, T. Ohkuma, M. Kitamura, H. Takaya, N. Sayo, H.
Kumobayashi, S. Akutagawa, J.Am.Chem.Soc. 1987, 109 5856-5858.
[3.] V. Ratovelomanana-Vidal, C. G. R. Touati, J. P. Tranchier, B. ben
Hassine, J.-P. Genêt, Adv.Synth.Catal. 2003, 345 261-274.
[4.] T. Sturm, W. Weissensteiner, F. Spindler, Adv.Synth.Catal. 2003, 345
160-164.
[5.] T. Yamano, N. Taya, H. Kawada, T. Huang, T. Imamoto, Tetrahedron
Lett. 1999, 40 2577-2580.
[6.] T. Ireland, K. Tappe, G. Grossheimann, P. Knochel, Chem.Eur.J. 2002,
8 843-852.
[7.] Y. G. Zhou, W. Tang, W. B. Wang, W. Li, X. Zhang, J.Am.Chem.Soc.
2002, 124 4952-4953.
[8.] M. T. Reetz, X. Li, Adv.Synth.Catal. 2006, 348 1157-1160.
[9.] W. Tang, X. Zhang, Chem.Rev. 2003, 103 3029-3069.
[10.] Y. H. Sun, X. B. Wan, M. J. Guo, D. H. Wang, X. C. Dong, Y. Pan, Z.
G. Zhang, Tetrahedron: Asymmetry 2004, 15 2185-2188.
[11.] H. Bernsmann, M. van den Berg, R. Hoen, A. J. Minnaard, G. Mehler,
M. T. Reetz, J. G. de Vries, B. L. Feringa, J.Org.Chem 2005, 70 943-
951.
Enantioselective Hydrogenation of α- and β-Ketoesters
using Monodentate Phosphoramidites Ligands
115
[12.] R. Hoen, J. A. F. Boogers, H. Bernsmann, A. J. Minnaard, A. Meetsma,
T. D. Tiemersma-Wegman, A. H. M. de Vries, J. G. de Vries, B. L.
Feringa, Angew.Chem.Int.Ed. 2005, 44 4209-4212.
[13.] A. J. Minnaard, B. L. Feringa, L. Lefort, J. G. de Vries, Acc.Chem.Res.
2007, 40 1267-1277.
[14.] M. van den Berg, A. J. Minnaard, E. P. Schudde, J. van Esch, A. H. M.
de Vries, J. G. de Vries, B. L. Feringa, J.Am.Chem.Soc. 2000, 122
11539-11540.
[15.] N. Mršic, L. Lefort, J. A. F. Boogers, A. J. Minnaard, B. L. Feringa, J. G.
de Vries, Adv.Synth.Catal. 2008, 350 1081-1089.
[16.] N. Mršic, T. Jerphagnon, A. J. Minnaard, B. L. Feringa, J. G. de Vries,
Adv.Synth.Catal. 2009, 351 2549-2552.
[17.] Q. Jing, X. Zhang, J. Sun, K. Ding, Adv.Synth.Catal. 2005, 347 1193-
1197.
[18.] Y. Xu, G. C. Clarkson, G. Docherty, C. L. North, G. Woodward, M.
Wills, J.Org.Chem. 2005, 70 8079-8087.
[19.] B. Hagemann, K. Junge, S. Enthaler, M. Michalik, T. Riermeier, A.
Monsees, M. Beller, Adv.Synth.Catal. 2005, 347 1978-1986.
[20.] K. Junge, B. Hagemann, S. Enthaler, G. Oehme, M. Michalik, A.
Monsees, T. Riermeier, U. Dingerdissen, M. Beller, Angew.Chem.Int.Ed.
2004, 43 5066-5069.
[21.] N. Andrushko, V. Andrushko, G. Köning, A. Spannenberg, A. Börner,
Eur.J.Org.Chem 2008, 847-853.
[22.] A. Korostylev, V. Andrushko, N. Andrushko, V. I. Tararov, G. Köning,
A. Börner, Eur.J.Org.Chem 2008, 840-846.
Chapter 4
116
[23.] V. I. Tararov, G. Köning, A. Börner, Adv.Synth.Catal. 2006, 348 2633-
2644.
[24.] J. P. Genêt, Acc.Chem.Res. 2003, 36 908-918.
[25.] L. Coutable, K. Adil, C. Saluzzo, Tetrahedron 2008, 64 11296-11303.
[26.] R. Noyori, T. Ohkuma, Angew.Chem.Int.Ed. 2001, 40 40-73.
[27.] R. Noyori, Adv.Synth.Catal. 2003, 345 15-32.
[28.] T. Ohkuma, R. Noyori, in Handbook of Homogeneous
Hydrogenation ,Vol. III, (Eds.: J. G. de Vries, C. J. Elsevier), Wiley-
VCH Verlag GmbH & Co. KGaA, Weinheim 2007, p. pp. 1105-1163.
[29.] A. Mortreux, A. Karim, in Handbook of homogeneous
hydrogenationEds.: J. G. de Vries, C. J. Elsevier), Wiley-VCH Verlag
GmbH & Co. KGaA, Weinheim 2007, p. pp. 1165-1191.
[30.] N. W. Boaz, E. B. Mackenzie, S. D. Debenham, S. E. Large, J. A.
Ponasik, J.Org.Chem 2005, 70 1872-1880.
[31.] S. Naili, I. Suisse, A. Mortreux, F. Agbossou, M. Ait Ali, A. Karim,
Tetrahedron Lett. 2000, 41 2867-2870.
[32.] C. Pasquier, S. Naili, A. Mortreux, F. Agbossou, L. Pélinski, J. Brocard,
J. Eilers, I. Reiners, V. Peper, J. Martens, Organometallics 2000, 19
5723-5732.
[33.] C. Pasquier, L. Pélinski, J. Brocard, A. Mortreux, F. Agbossou-
Niedercorn, Tetrahedron Lett. 2001, 42 2809-2812.
[34.] K. Mashima, K. h. Kusano, N. Sato, Y. i. Matsumura, K. Nozaki, H.
Kumobayashi, N. Sayo, Y. Hori, T. Ishizaki, J.Org.Chem. 2002, 59
3064-3076.
Enantioselective Hydrogenation of α- and β-Ketoesters
using Monodentate Phosphoramidites Ligands
117
[35.] Y. Chen, J. Xu, X. Xu, Y. Xia, H. Lin, S. Xia, L. Wang, Tetrahedron:
Asymmetry 2007, 18 2537-2540.
[36.] W. Yang, J. H. Xu, Y. Xie, Y. Xu, G. Zhao, G. Q. Lin, Tetrahedron:
Asymmetry 2006, 17 1769-1774.
[37.] D. Zhu, J. E. Stearns, M. Ramirez, L. Hua, Tetrahedron 2006, 62 4535-
4539.
[38.] D. M. Zhu, Y. Yang, J. D. Buynak, L. Hua, Org.Biomol.Chem. 2006, 4
2690-2695.
[39.] Q. Meng, Y. Sun, V. Ratovelomanana-Vidal, P. Jean, Z. Zhang,
J.Org.Chem. 2008, 73 3842-3847.
[40.] Y. Sun, X. Wan, J. Wang, Q. Meng, H. Zhang, L. Jiang, Z. Zhang,
Org.Lett. 2005, 7 5425-5427.
[41.] H. Tone, M. Buchotte, C. Mordant, E. Guittet, T. Ayad, V.
Ratovelomanana-Vidal, Org.Lett. 2009, 11 1995-1997.
[42.] D. J. Milanowski, K. R. Gustafson, M. A. Rashid, L. K. Pannell, J. B.
McMahon, M. R. Boyd, J.Org.Chem. 2004, 69 3036-3042.
[43.] A. Fürstner, E. Kattnig, O. Lepage, J.Am.Chem.Soc. 2006, 128 9194-
9204.
[44.] Topics in Heterocyclic Chemistry, (Ed.: N. Motohashi) Springer GmbH,
Berlin 2009.
[45.] T. Eicher, E. Hauptmann, R. Besenbruch, The chemistry of heterocycles:
structure, reactions, synthesis and applications, Thieme, New York
1995.
[46.] Bosch, B. E., Eckert, M., Militzer, H.-C., and Dreisbach, C. Process for





[47.] Reddy, K. R. and Erion, M. D. Novel 2'-C-methyl nucleoside derivatives.
Janofsky & Walker LLP. [US 2005182252]. 2005.
Ref Type: Patent
[48.] R. Hulst, N. K. de Vries, B. L. Feringa, Tetrahedron: Asymmetry 1994,
5 699-708.
[49.] M. T. Reetz, G. Mehler, O. Bondarev, Chem.Commun 2006, 2292-2294.
[50.] J. F. Bower, T. Riis-Johannessen, P. Szeto, A. J. Whitehead, T.
Gallagher, Chem.Commun. 2007, 728-730.
[51.] S. Rodríguez, M. M. Kayser, J. D. Stewart, J.Am.Chem.Soc. 2001, 123
1547-1555.
[52.] J.-P. Genêt, C. Pinel, V. Ratovelomanana-Vidal, S. Mallart, X. Pfister, L.
Bischoff, M. C. C. Deandrade, S. Darses, C. Galopin, J. A. Laffitte,
Tetrahedron-Asymmetry 1994, 5 675-690.
[53.] C. W. Bradshaw, H. Fu, G. J. Shen, C. H. Wong, J.Org.Chem. 1992, 57
1526-1532.






In this chapter the attempts to perform an asymmetric hydrogenation on α-substituted β-
ketoesters and α-aryl aldehydes are described. In the hydrogenation of the α-substituted
β-ketoesters no syn/anti selectivity was obtained when using a ruthenium based catalyst
containing phosphoramidite ligands. For the α-aryl aldehydes full conversions and





As discussed in Chapter 1, kinetic resolution is one of the methods to obtain an
enantiopure compound. In a kinetic resolution, a reaction is performed in which
one of the two enantiomers of the substrate reacts (much) faster than the other.
In this way one of the enantiomers is reacted away and the other enantiomer is
left in enantioenriched form. The major drawback of this method for making an
enantiopure compound is the fact that the maximum yield for these reactions is
only 50%, since only half of the substrate will react.
Figure 1: Kinetic resolution vs. dynamic kinetic resolution
If it would be possible to transform the other, non reacting, enantiomer into the
reacting enantiomer while the resolution is taking place, it would be possible to
obtain a yield higher than 50% and even go to full conversion. This process, in
which the non-reactive enantiomer is transformed via, for instance, a
racemization reaction into the reactive enantiomer during the resolution, is called
a dynamic kinetic resolution (DKR).[1]
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5.1.1 Dynamic kinetic resolution of α-substituted β-ketoesters
A class of substrates on which a DKR can readily be performed comprizes the α-
substituted β-ketoesters because of their rapid racemization which occurs even at
room temperature. The hydrogenation of these compounds has been an area of
interest for quite some years. Since, if done correctly, one is able to control the
formation of two stereogenic centers in one reaction step. A lot of work has been
carried out on this subject by the group of Noyori after their discovery of the
ruthenium-binap system.[2] They have proven to be able to hydrogenate methyl
2-(benzamidomethyl)-3-oxobutanoate (5.1) with excellent de and ee.[3]
Figure 2: Industrial synthesis of a carbapenem intermediate via an enantioselective
hydrogenation under DKR conditions.
This selective hydrogenation led to the development of an industrial scale
process for the synthesis of an intermediate in the production of carbapenems










Figure 3: The structure of the natural product borrelidin (5.3) with, indicated by the
ellipse, the part of the molecule which could be constructed using a DKR hydrogenation
on a β-ketoester
Being able to control two stereocenters in one reaction step makes the synthesis
of molecules containing multiple stereocenters a lot easier since it reduces the
number of chirality introducing steps. In our group the natural antibiotic
borrelidin (5.3)[4] (Figure 3) is being synthesized. This molecule contains a part
which has been synthesized via asymmetric hydrogenation and DKR.
5.1.2 Enantioselective hydrogenation of aldehydes
Figure 4: Hydrogenation of α-aryl aldehydes under DKR conditions.
Another class of substrates that can be interesting for hydrogenation under DKR
conditions consists of α-aryl aldehydes. The stereogenic center of this type of
aldehydes is known to racemize easily under basic conditions, due to the keto-
enol tautomerism the aldehydes are, continuously, undergoing. By choosing the
reaction conditions correctly it has been shown that it is possible to hydrogenate
these aldehydes into enantiomerically enriched primary β-aryl alcohols.
So far, two examples are known of the enantioselective hydrogenation of aryl
aldehydes. One by the group of List[5], who used a ruthenium catalyst containing
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binap and DPEN as ligands, and the other one, reported by Zhou[6], who used a
catalyst containing their SDP ligand (5.4a-e, Figure 5) in combination with a
1,2-diamine. Both systems have shown to be able to hydrogenate the aldehyde
substrates in excellent yields and up to 99% ee.
Figure 5: The different SDP ligands (5.4a-e) as used by the group of Zhou in the
asymmetric hydrogenation of aldehydes.[6;7]
The products of these hydrogenations can be used in the synthesis of several
biologically interesting compounds. As shown by the group of List it is possible
to synthesize Ibuprofen® in two steps from the 2-(4-(sec-butyl)phenyl)-
propionaldehyde. After the hydrogenation, KMnO4 is used for the oxidation of
the alcohol to the desired acid, keeping the stereogenic center in tact (still 92%
ee after oxidation).[8]
Figure 6: Synthesis of Ibuprofen as proposed by Li and List.[5]
In the synthesis of the pesticide Fenvalerate and the lipoxygenase inhibitor BAY
x 1005[9] the hydrogenation of an α-aryl aldehyde can also be used as key step
for the introduction of chirality.
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Figure 7: Structures of Fenvalerate and BAY X 1005 made by hydrogenation of an α-
aryl aldehyde.[6]
Besides the α-aryl aldehydes, the group of Zhou also reported the asymmetric
hydrogenation of α-aryloxy aldehydes[7] (Figure 8) under the same conditions.
Figure 8: The α-aryloxy aldehydes which can also undergo asymmetric hydrogenation
under DKR conditions.
They were able to reach excellent yields, up to 98%, and moderate to good ee’s,
up to 81% using a ruthenium catalyst containing their DMM-SDP (5.4e) ligand
(see Figure 5) in combination with the diamine DACH.
In this chapter the results will be discussed of the hydrogenation of ethyl 2-
methylacetoacetate (5.5) using a ruthenium catalyst based on phosphoramidite
ligands. In the second part of the chapter, the synthesis of several α-
arylaldehydes will be described. Also the search for a good, ruthenium based,
hydrogenation catalyst for these aldehydes, using phosphoramidite ligands, will
be discussed.
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5.2 Results
The good results we obtained in the asymmetric hydrogenation of acetophenones
and β-ketoesters as described in chapters 2 and 4, respectively, prompted us to
also try the phosphoramidite ligands in hydrogenations under DKR conditions.
5.2.1 Hydrogenation results of α-substituted β-ketoesters
The asymmetric hydrogenation of ethyl 2-methyl-acetoacetate (5.5) was tested
with the same catalyst that was used for the hydrogenation of β-ketoesters as
described in chapter 4, thus a ruthenium catalyst in combination with two
monodentate phosphoramidite ligands.
Table 1: Ligand screening in the hydrogenation of 5.5 under DKR conditions.
Ligand Conversion (%) syn:anti ee syn (%) ee anti (%)
(S)-L1 35 7:9 71 33
(S)-L1a 76 5:9 71 33
(S)-L1b 48 1:1 0 0
(S)-L1c 49 2:3 71 29
(S)-L2 15 8:9 31 19
(S)-L3 21 1:1 32 11
(R)-L4 18 1:1 28 15
(S)-L5 20 1:1 25 8
(R)-L6 10 1:1 -19 -9
Unless stated otherwise, reactions were carried out on 2 mmol of 5.5 catalyzed by 0.25
mol% ruthenium-phosphoramidite catalyst in 4 mL MeOH, 70 bar H2 at 70 oC for 24 h.
Catalysts where made as described in chapter 4. Substrate/Ru/L 400/1/4. a) Reaction
time: 48 h. b) 5% KOtBu added to the reaction mixture c) 0.5 mol% catalyst used.
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Conversion, syn:anti-ratio and ee’s were determined via chiral GC using a Chiralsil Dex-
CB column isothermal (110 oC) conditions.
As can be seen in Table 1, the hydrogenation of 5.5 is much slower compared to
β-ketoesters that do not have a substitution on the α-position. It was not possible
to get the reaction to go to full completion within 24 hours. Also we were not
able to achieve good selectivity for the syn or the anti product. The best
selectivity we were able to get was a 3:2 ratio in favor of the anti product when
we used 0.5 mol% of the catalyst which has the L1 ligand. Disappointing also
was the fact that of the two products it was the syn that displayed the higher ee;
71% in comparison to 29% for the more abundant anti product!
Another substrate tested in the asymmetric hydrogenation under DKR conditions
was methyl 2-oxocyclopentanecarboxylate (5.7). The product of this
hydrogenation is of great interest for our research group since it could be used as
one of the precursors in the synthesis of borrelidin. The selective hydrogenation
of this substrate can be achieved using a Ru binap type catalyst.[3] The interest
within our group for the product of this hydrogenation prompted us to attempt it
using a Ru-phosphoramidite catalyst.
Figure 9: Asymmetric hydrogenation of methyl 2-oxocyclopentane carboxylate (5.7) in
which no conversion was observed when a phosphoramidite ligand as used.
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Sadly, in none of hydrogenation reactions of 5.7 in which a phosphoramidite
ligand was used any conversion was observed. Also a switch in solvent from
methanol to DCM did not get the reaction started.
With these disappointing results in hand we decided to try a different class of
substrates which could also undergo asymmetric hydrogenation under DKR
conditions.
5.3 Synthesis of α-arylaldehydes
Figure 10: Synthesis of the α-branched arylaldehydes.
The various α-substituted arylaldehydes were synthesized as previously
described by Xie et al.[6] and Yamazaki et al.[10] starting from the corresponding
ketones. On these substrates a Wittig methoxymethylenation was performed
using (methoxymethyl)triphenylphosphonium chloride with KOtBu as a base.
This resulted in the corresponding enol-methyl ethers. An acid catalyzed
hydrolysis, using hydrochloric acid, gave the various arylaldehydes (5.9b-h) in
moderate to good yields (51-72%), over two steps, as shown in Figure 11.
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Figure 11: The α-alkylated phenyl acetaldehydes with the yields over two steps.
Aldehyde 5.9a is commercially available.
5.4 Results of the asymmetric hydrogenation of α-arylaldehydes
In order to get good results in the asymmetric hydrogenation of aryl aldehydes
we had to make sure that the base induced racemization of the starting material
was faster than the rate of hydrogenation. If this would not be the case the
catalyst would eventually have no choice but to start hydrogenation the non-
preferred enantiomer of the starting material.
Figure 12: Base induced racemization during dynamic kinetic resolution in the
hydrogenation of aldehydes.
By stopping the hydrogenation reaction at different times before full completion
we were able to check the ee of the starting material.
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In all cases, chiral-GC analysis of the reaction mixture showed that the starting
material remained a racemic mixture. This was proof that the racemization was
fast enough to keep up with the actual DKR hydrogenation experiments.
In the hydrogenation of hydratropaldehyde (5.9a) we started with the catalyst
that performed best in the hydrogenation of simple aryl ketones. Using (R)-L1,
different combinations with diamines were tested as well as different amounts of
base to get the right combinations for this type of hydrogenation. As can be seen
in Table 2 the best results in this type of hydrogenations are obtained when using
a diamine of opposite configuration as the phosphoramidite.
Table 2: Results of ligand diamine combinations






1 (R)-L6 (R,R)-DACH 12 85 −62
2 (R)-L6 (S,S)-DACH 12 full (85) 83
3 (R)-L6 (R,R)-DACH 24 full (93) −33
4 (R)-L6 (S,S)-DPEN 12 full (90) 32
5 (R)-L6 (S,S)-DPEN 24 full (90) 29
All reactions were carried out on 2 mmol of 5.9a with 0.25 mol% Ru-catalyst, which
was made the same way as described in chapter 2, in a total volume of 4 mL while
applying 50 bar H2 pressure at room temperature for 24 hours.
Substrate/Ru/PPA/Diamine 400/1/2/1. a) Number in parentheses is the isolated yield of
the product. b) Ee’s were determined via chiral GC using a Chiralsil Dex-CB column.
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Table 3: Results of the ligand screening in the asymmetric hydrogenation of
hydratropaldehyde.
Ligand Conversion (%) ee (%)
1 (R)-L6 full 83
2 (S)-L7 70 −14
3 (S)-L8 40 −28
4 (R)-L3 full 71
5 (S)-L5 full −51
6 (S)-L2 <10 nd
7 (S)-L9 <10 nd
8 (S)-L10 <10 nd
9 (S)-L11 <10 nd
10 (S)-L12 <10 nd
Unless stated otherwise all reactions were carried out on 2 mmol 5.9a with 0.25 mol%
ruthenium catalyst bearing the mentioned PPA-ligand in combination with DACH of the
opposite absolute configuration.
After finding a catalyst and conditions that led to full conversion but induced an
ee that is up for improvement, a small screening of ligands was done. As shown
in Table 3 none of the ligands led to a better performing catalyst than the
DiMePip ligand L6 which was used in first instance.
Asymmetric hydrogenation under DKR conditions
131
Use of MonoPhos, L7, and the somewhat bigger Et-Propyl ligand L8 did not
result in full conversion within 20 hours. Also the ee’s reached after the 20 hours
of 14% and 28% respectively were nowhere near the level reached when L6 was
used. The even bulkier phosphoramidites, di-isopropyl phosphoramidite L9 and
Leggy ligand L10, performed even worse, as hardly any conversion and a
negligible ee were observed. Also the two NH-ligands L11 and L12 and the very
bulky 8H-Ph-piperazine L2 did not result in conversion and ee. The only two
ligands which allowed us to obtain similar results as with DiMePip were the two
ligands that had a substitution on the 3,3’-position of the binol backbone. Both
the 3,3’-DiMethyl-Morfphos (L3) and the 3,3’-dibromo-Pipphos (L5) ligands
induced full conversion and 71% and 51% ee, respectively. This indicates again
the importance of the extra bulk created at these positions with respect to





After it was concluded that none of the tested ligands gave a better result in the
asymmetric hydrogenation of hydratropaldehyde we decided to explore the
substrate scope of the reaction with the catalyst that was used in first instance.
This is the ruthenium catalyst which bears the phosphoramidite (R)-L6 in
combination with the diamine (S,S)-DACH. The results of these reactions can be
found in Table 4. It can be seen that also varying the substrate did not lead to a
higher ee either.
Table 4: Results of the asymmetric hydrogenation of different α-aryl aldehydes.
Aldehyde R1 R2 Conversiona,b (%) eea (%)
1 5.9a H Me full (95) 83
2 5.9b H iPr full (91) 74
3 5.9c H nPr full (96) 71
4 5.9d H cPr full (90) 78
5 5.9e H Cyclohexyl full (89) 78
6 5.9f o-Me Me full (92) 69
7 5.9g p-OMe Me full (89) 62
8 5.9h p-Cl Me full (87) 63
All reactions were carried out on 1 mmol substrate with 0.25 mol% Ru catalyst bearing
two (R)-L6 and (S,S)-DACH in the presence of 12 mol% KOtBu in a total volume of 2
mL iPrOH. During the reaction 50 bar H2 was applied for 20 hours at room temperature.
a) Conversion and ee’s were determined via chiral-GC using a Chiralsil Dex-CB column.
All products are of (R)-configuration. b) Number in parentheses denotes isolated yield.
What does become clear from this table is that the substituent on the alpha
position or on the phenyl ring does not influence the outcome of the reaction
very much. In all cases the reaction goes to full completion and the ee’s are all
moderate to good (62 – 83%). Selectivity-wise it can be seen that the ee drops a
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little bit when a substituent is placed on the phenyl ring (5.9f-h), although it does
not seem to matter whether these substituents are electron withdrawing (5.9h),
electron donating (5.9g) or a more sterically demanding o-methyl group (5.9f).
In all cases the ee drops about 15-20% compared to the best performing
substrate 4a. Placing different substituents on the alpha position (5.9b-e) does
not seem to make much difference since in all cases the ee remains about the
same. If anything it can be said, it is that the introduction of a cycloalkane (5.9d-
e) makes the reaction a bit more selective in comparison to the non cyclic side
chains (5.9b-c).
5.6 Conclusions
It is concluded that the hydrogenation of 5.5 under DKR conditions is possible.
Unfortunately, the selectivity in this hydrogenation is not very high. Mostly
equimolar mixtures of syn and anti product are formed with at best a 9:5 ratio in
favor of the anti product. The ee’s of the major diastereomer are at best moderate.
The minor diastereomer displayed better enantioselectivity up to a good 71%.
Also it appeared that the reaction proceeded much slower in comparison with
that of the unsubstituted β-ketoesters (See Chapter 4), and did not go to full
conversion. Apparently the extra substituent on the α-position made the substrate
less likely to coordinate to the catalyst. In the case of substrate 5.7 the ring
structure made it even impossible for the substrate to be hydrogenated using
phosphoramidite ligands in the catalyst.
The α-aryl aldehydes could be fully hydrogenated in most cases, however, the
selectivity of the reaction is only moderate. It appears that the phosphoramidite
ligands in combination with the chiral 1,2-diamine, in this case, cannot create an





For general experimental remarks see Chapter 2. Substrates 5.5, 5.7 as well as the
ketones used in the aldehyde synthesis were purchased from Aldrich and used as
received. The Ph3P+CH2OCH3 Cl- was obtained from Alfa Aesar. Ligands L4 and L6 are
previously described in this thesis, L1,[11] L2,[12] L3,[11] L7,[13] L8,[14] L9-10,[11] L11[15]
and L12[16] were all described in literature before.
Procedure for the hydrogenation of ethyl 2-methyl-acetoacetate (5.5)
In 2 mL DMF 1.5 mg (2.5 μmol) [RuCl2(cymene)]2 and 4 eq (10 μmol) phosphoramidite
were dissolved. The solution was heated at 90 oC for two hours while stirring. After two
hours the solution was cooled down to room temperature after which the DMF was
removed in vacuo. The residue was redissolved in 4 mL MeOH. The solution containing
the catalyst was transferred to a glass vial loaded with 288 mg (2 mmol) 5.5 and a
stirring bar. The vial was closed with a septum cap. The septum was pierced with a
hypodermic needle and placed in an autoclave. After the autoclave was closed it was
purged three times with 5 bar N2 and three times with 8 bar H2. After purging the
pressure was set at 70 bar and the autoclave was heated till 70 oC for 24 hours. When the
reaction time had passed, the autoclave was let to cool down to room temperature and
the hydrogen pressure was carefully released. After evaporation of the solvent the
residue was passed over a small silica column. Ethyl 2-methyl-3-hydroxybutanoate (5.6)
was obtained as a mixture of four products (R,S)-5.6, (R,R)-5.6, (S,R)-5.6 and (S,S)-5.6.
1H-NMR (200 MHz, CDCl3) δ (ppm) 4.38-4.01 (m, 6H), 2.56-2.41 (m, 2H), 1.37-1.17
(m, 18H). 13C-NMR (50 MHz, CDCl3) δ (ppm) 170.5, 67.9, 61.3, 45.4, 21.8, 14.0, 12.7.
Ee’s and syn / anti ratios were determined via chiral GC[17], Chiralsil Dex-CB Tinlet = Tdet
= 250 oC; Tstart = 110 oC (50 min) – (10 oC / min)  180 oC. TS,S = 33.45 min, TR,S =
34.19 min, TS,R = 34.47 min, TR,R = 35.37 min.
General procedure for the aldehyde synthesis: A suspension of 5.1 gram
Ph3P+CH2OCH3 Cl- (15 mmol) in 40 mL ether was cooled to 0 oC and 2.0 gram KOt-Bu
(17.5 mmol, 1.2 equiv.) was added in portions to give a dark red solution. After stirring
this mixture for 30 minutes, a solution of 0.66 eq of ketone (10 mmol) in 10 mL ether
was added dropwise to the solution containing the Wittig reagent. The resulting mixture
was stirred at 0 oC for 30 minutes, after which it was allowed to warm up to room
temperature and kept stirring until the reaction was finished (TLC monitor). When the
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reaction was completed, the mixture was poured into 75 mL of water. The layers were
separated and the aqueous layer was extracted twice with EtOAc (30 mL). The combined
organic layers were washed with water (50 mL) and brine (50 mL), dried over MgSO4,
and concentrated in vacuo. The residue was purified on a silica gel column with a
ether/pentane (1 : 20) mixture as eluent to afford the enol-methyl ether.
This enol-methyl ether was dissolved in Et2O (30 mL) and to this solution was slowly
added a 70% aqueous solution of HClO4 (~3 mL). After stirring for several hours (TLC
monitor) at room temperature the mixture was added slowly to a saturated aqueous
NaHCO3 solution (100 mL). The organic layer was separated and the aqueous layer was
extracted twice with 30 mL Et2O. The combined organic layers were dried over MgSO4,
and the solvent was removed under reduced pressure. The residue was purified on a
silica gel column with a ether/pentane (1 : 20) mixture as eluent to afford the
corresponding α-aryl aldehyde as an oil in reasonable to good yields.
2-phenyl-3-methylbutanal[6] (5.9b)
The product was obtained as a colorless oil after column chromatography,
1.02 gram (6.31 mmol 63%). 1H-NMR (200 MHz, CDCl3) δ (ppm) 9.70 (d,
J = 3.2 Hz, 1H), 7.37-7.16 (m, 5H), 3.18 (dd, J = 3.2 Hz, J = 9.4 Hz, 1H),
2.47-2.33 (m, 1H), 1.04 (d, J = 6.8 Hz, 3H), 0.77 (d, J = 6.8 Hz, 3H). 13C-NMR (50 MHz,
CDCl3) δ (ppm) 201.1, 134.9, 129.3, 128.9, 127.4, 66.8, 28.8, 21.2, 20.0. HRMS (EI)
calcd for C11H14O (M+) 162.1045 found 162.1051.
2-phenylpentanal[18] (5.9c)
The product was obtained as a colorless oil after column chromatography,
0.98 gram (6.02 mmol, 60%). 1H-NMR (200 MHz, CDCl3) δ (ppm) 9.66
(d, J = 1.9 Hz, 1H), 7.38-7.17 (m, 5H), 3.51 (dt, J = 2.0 Hz, J = 3.5 Hz,
1H), 1.83-1.60 (m, 2H), 1.32-1.22 (m, 2H), 0.92 (t, J = 7.2 Hz, 3H). 13C-
NMR (50 MHz, CDCl3) δ (ppm) 201.1, 134.8, 129.0, 128.8, 127.5, 58.4, 31.8, 20.3, 13.9.
HRMS (EI) calcd for C11H14O (M+) 162.1045 found 162.1049.
2-cyclopropyl-2-phenylacetaldehyde[19] (5.9d)
The product was obtained as a colorless oil after column chromatography,
0.94 gram (5.89 mmol, 59%). 1H-NMR (200 MHz, CDCl3) δ (ppm) 9.75






1H), 1.41-1.23 (m, 1H), 0.82-0.55 (m, 2H), 0.44-0.17 (m, 2H). 13C-NMR (50 MHz,
CDCl3) δ (ppm) 197.0, 132.9, 125.5, 125.2, 124.2, 59.9, 7.5, 1.1, 0.0. HRMS (EI) calcd
for C11H12O (M+) 160.0888 found 160.0877.
2-cyclohexyl-2-phenylacetaldehyde[20] (5.9e)
The product was obtained as a colorless oil after column chromatography,
1.38 gram (6.84 mmol, 68%). 1H-NMR (200 MHz, CDCl3) δ (ppm) 9.69
(d, J = 3.6 Hz, 1H), 7.40-7.14 (m, 5H), 3.25 (dd, J = 3.5 Hz, J = 9.7 Hz,
1H), 2.20-2.01 (m, 1H), 1.87-1.62 (m, 4H), 1.44-0.95 (m, 4H), 0.90-0.70
(m, 2H). 13C-NMR (50 MHz, CDCl3) δ (ppm) 201.2, 135.2, 129.3, 128.9, 127.4, 65.8,
38.2, 31.8, 30.2, 26.2, 26.0. HRMS (EI) calcd for C14H18O (M+) 202.1358 found
202.1351.
2-(2-methylphenyl)-propanal[21] (5.9f).
The product was obtained as a colorless oil after column chromatography
1.06 gram (7.16 mmol, 72%). 1H-NMR (200 MHz, CDCl3) δ (ppm) 9.66,
(d, J = 1.5 Hz, 1H), 7.28-7.16 (m, 2H), 7.09-7.02 (m, 2H), 3.84 (dq, J = 1.3 Hz, J = 6.9
Hz, 1H), 2.36 (s, 3H), 1.41 (d, J = 7.1 Hz, 3H). 13C-NMR (50 MHz, CDCl3) δ (ppm)
201.1, 136.3, 130.9, 127.5, 127.4, 126.7, 49.3, 19.6, 14.3. HRMS (EI) calcd for C10H12O
(M+) 148.0888 found 148.0892.
2-(4-metoxyphenyl)-propanal[22] (5.9g)
The product was obtained as a colorless oil after column
chromatography, 1.12 gram (6.83 mmol, 68%) 1H-NMR (200 MHz,
CDCl3) δ (ppm) 9.65 (d, J = 1.4 Hz, 1H), 7.15-7.09 (m, 2H), 6.95-6.88
(m, 2H), 3.81 (s, 3H), 3.60-3.56 (m, 1H), 1.41 (d, J = 7.1 Hz, 3H) 13C-NMR (50 MHz,
CDCl3) δ (ppm) 201.2, 159.0, 129.6, 129.3, 114.5, 66.3, 52.1, 14.7. HRMS (EI) calcd for
C10H12O2 (M+) 164.0837 found 164.0849.
2-(4-chlorophenyl)-propanal[22] (5.9h)
The product was obtained as a yellow oil after column
chromatography, 0.85 gram (5.06 mmol, 51%). 1H-NMR (200 MHz,
CDCl3) δ (ppm) 9.66 (d, J = 1.2 Hz, 1H), 7.47-7.08 (m, 4H), 3.48 (q, J
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136.2, 133.1, 129.6, 129.2, 65.8, 14.6. HRMS (EI) calcd for C9H9ClO (M+) 168.0342
found 168.0337.
General procedure for the hydrogenation of the aldehydes: In 2 mL DMF were
dissolved 1.5 mg (2.5 μmol) [RuCl2(cymene)]2 and 10 μmol (4 equiv) phosphoramidite
ligand. The solution was heated at 90 oC for two hours while stirring. Subsequently, the
solution was cooled down to room temperature after which 5 μmol (2 equiv.) of diamine
were added and the solution was stirred for an additional 16 hours. After overnight
stirring the DMF was removed in vacuo and the residue was stripped twice with toluene
and washed once with hexane. The now remaining powder was redissolved in 2 mL
iPrOH. The solution containing the catalyst was transferred to a glass vial loaded with 1
mmol of the aldehyde substrate and a stirring bar. Just prior to placing the vial in the
autoclave 0.12 mL of a 1.0M KOtBu solution was added to the solution. The vial was
closed with a septum cap. The septum was pierced with a hypodermic needle and placed
in an autoclave. After the autoclave was closed it was purged three times with 5 bar N2
and three times with 8 bar H2. After purging the pressure was set to 50 bar and the
autoclave was placed on a stirring plate and stirred at room temperature for 24 hours.
The hydrogen pressure was carefully released. After evaporation of the solvent a small
sample of the residue was passed over a silica plug in order to obtain a GC sample.
Conversion and ee were determined via 1H-NMR and chiral GC respectively.
All alcohols were made via the hydrogenation using (R)-DimethylPipPhos (L6) and
(S,S)-DACH.
(R)-2-phenylpropan-1-ol[6] (5.10a)
The product was obtained as a colorless oil in 95% yield. [α]D = 13.3 (c
1.19, CHCl3), 83% ee. 1H-NMR (200 MHz, CDCl3) δ (ppm) 7.42-7.01
(m, 5H), 3.70 (d, J = 6.8 Hz, 2H), 3.03-2.86 (m, 1H) 1.28 (d, J = 7.0 Hz, 3H). 13C-NMR
(50 MHz, CDCl3) δ (ppm) 143.6, 128.6, 137.5, 126.7, 68.7, 42.4, 17.6. Ee determination
was carried out on Chiralsil Dex-CB column Tinlet = Tdet = 250 oC; Tstart = 100 oC (35 min)





The product was obtained as a colorless oil in 91% yield. [α]D = −9.9 (c
1.14, CHCl3), 74% ee. 1H-NMR (200 MHz, CDCl3) δ (ppm) 7.37-7.20
(m, 5H), 4.01-3.77 (m, 2H), 2.56-2.45 (m, 1H), 1.94-1.84 (m, 1H), 1.20
(d, J = 6.2 Hz, 1H), 1.01 (d, J = 6.6 Hz, 3H), 0.73 (d, J = 6.7 Hz, 3H). 13C-NMR (50
MHz, CDCl3) δ (ppm) 141.7, 128.7, 128.5, 126.7, 65.2, 55.8, 30.1, 21.0. Ee
determination was carried out on Chiralsil Dex-CB column Tinlet = Tdet = 250 oC; Tstart =
100 oC (30 min) – (10 oC / min) 180 oC. TS = 26.86 min; TR = 26.93 min.
(R)-2-phenylpentan-1-ol[23] (5.10c)
The product was obtained as a colorless oil in 96% yield. [α]D = −8.3 (c
1.05, CHCl3), 71% ee. 1H-NMR (200 MHz, CDCl3) δ (ppm) 7.36-7.20
(m, 5H), 3.80-3.65 (m, 2H), 2.81-2.78 (m, 1H), 1.71-1.50 (m, 2H),
1.34 (bs, 1H), 1.25-1.22 (m, 2H), 0.87 (t, J = 7.1 Hz, 3H). 13C-NMR (50 MHz, CDCl3) δ
(ppm) 142.5, 128.6, 128.1, 126.8, 67.7, 48.4, 34.2, 20.5, 14.1. Ee determination was
carried out on Chiralsil Dex-CB column Tinlet = Tdet = 250 oC; Tstart = 110 oC (3 min) – (1
oC / min) 180 oC. TS = 52.85 min; TR = 53.05 min.
(R)-2-cyclopropyl-2-phenylethanol[24] (5.10d)
The product was obtained as a colorless oil in 90% yield. [α]D = −8.5 (c
0.93, CHCl3), 78% ee. 1H-NMR (200 MHz, CDCl3) δ (ppm) 7.40-7.20
(m, 5H), 3.89-3.86 (m, 2H), 2.09-1.98 (m, 1H), 1.45 (bs, 1H), 1.11-0.93
(m, 1H), 0.71-0.58 (m, 1H), 0.51-0.26 (m, 2H), 0.16-0.04 (m, 1H). 13C-NMR (50 MHz,
CDCl3) δ (ppm) 139.3, 125.5, 124.9, 123.7, 64.5, 50.3, 10.2, 2.0, 0.0. Ee determination
was carried out on Chiralsil Dex-CB column Tinlet = Tdet = 250 oC; Tstart = 110 oC (3 min)
– (1 oC / min) 180 oC. TR = 47.59 min; TS = 49.59 min.
(R)-2-cyclohexyl-2-phenylethanol[6] (5.10e)
The product was obtained as a white solid, Mp = 48-50 oC, in 89% yield.
[α]D = −4.7 (c 0.95, CHCl3), 78% ee. 1H-NMR (200 MHz, CDCl3) δ
(ppm) 7.37-7.16 (m, 5H), 4.04-3.77 (m, 2H), 2.62-2.51 (m, 1H), 1.91-
0.76 (m, 11H) 13C-NMR (50 MHz, CDCl3) δ (ppm) 141.7, 128.8, 128.5,
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Chiralsil Dex-CB column Tinlet = Tdet = 250 oC; Tstart = 110 oC (3 min) – (1 oC / min) 
180 oC. TS = 69.16 min; TR = 69.44 min.
(R)-2-(2-methylphenyl)-propan-1-ol[25] (5.10f)
The product was obtained as a colorless oil in 92% yield. [α]D = 10.1 (c
1.16, CHCl3), 69% ee. 1H-NMR (200 MHz, CDCl3) δ (ppm) 7.22-7.07
(m, 4H), 3.80-3.63 (m, 2H), 3.27-3.17 (m, 1H), 2.36 (s, 3H), 1.41 (bs, 1H), 1.24 (d, J =
6.9 Hz, 3H) 13C-NMR (50 MHz, CDCl3) δ (ppm) 141.7, 136.4, 130.5, 126.3, 126.3,
125.4, 68.0, 37.2, 19.6, 17.5. Ee determination was carried out on Chiralsil Dex-CB
column Tinlet = Tdet = 250 oC; Tstart = 100 oC (30 min) – (10 oC / min)  180 oC. TS =
24.80 min; TR = 24.91 min.
(R)-2-(4-methoxyphenyl)-propan-1-ol[23] (5.10g)
The product was obtained as a colorless oil in 89% yield. [α]D = 9.6 (c
1.11, CHCl3), 62% ee. 1H-NMR (200 MHz, CDCl3) δ (ppm) 7.19-
7.13 (m, 2H), 6.91-6.84 (m, 2H), 3.79 (s, 3H), 3.66 (d, J = 7.0 Hz, 2H),
2.92-2.82 (m, 1H), 1.25 (d, J = 7.0 Hz, 3H). 13C-NMR (50 MHz, CDCl3) δ (ppm) 158.3,
135.6, 128.4, 114.0, 68.8, 55.3, 41.6, 17.7. Ee determination was carried out on Chiralsil
Dex-CB column Tinlet = Tdet = 250 oC; Tstart = 110 oC (3 min) – (1 oC / min)  180 oC.
TS = 31.65 min; TR = 33.21 min.
(R)-2-(4-chlorophenyl)-propan-1-ol[26] (5.10h)
The product was obtained as a colorless oil in 87% yield. [α]D = 5.3
(c 0.98, CHCl3), 63% ee. 1H-NMR (200 MHz, CDCl3) δ (ppm) 7.33-
7.27 (m, 2H), 7.20-7.15 (m, 2H), 3.71-3.62 (m, 2H), 2.95-2.86 (m,
1H), 1.52 (bs, 1H), 1.24 (d, J = 6.9 Hz, 3H). 13C-NMR (50 MHz, CDCl3) δ (ppm) 142.2,
132.4, 128.9, 128.7, 68.5, 41.7, 17.5. Ee determination was carried out on Chiralsil Dex-
CB column Tinlet = Tdet = 250 oC; Tstart = 100 oC (30 min) – (10 oC / min) 180 oC. TS =
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In the year 2000 several groups rediscovered the use of monodentate ligands in
asymmetric hydrogenation.[1-3] The search for new methodologies using these
monodentate ligands instead of bidentate ligands in several types of asymmetric
hydrogenation reactions has been a topic of great interest since then. In our
group a number of methods have successfully been developed using
monodentate phosphoramidite ligands in the asymmetric hydrogenation of
olefinic[4;5] and imine[6] type substrates.[7]
The goal of the research described in this thesis was to develop methodologies
for the asymmetric hydrogenation of different types of ketones using
monodentate phosphoramidite ligands. Here the conclusions of this research are
presented and a brief outlook towards future research is given.
6.2 Conclusions
We have shown that monodentate phosphoramidites are highly versatile chiral
ligands in the ruthenium catalyzed asymmetric hydrogenation of several types of
carbonyl compounds.
In chapter 2 we showed that a ruthenium catalyst containing a chiral diamine and
two bulky phosphoramidite ligands, all with the same absolute configuration,
was able to hydrogenate a range of acetophenone type ketones in good yields
and enantioselectivities. The best performing combination was found to be the
one in which DACH is used in combination with the phosporamidite ligand 3-
3’-dimethyl PipPhos (See Figure 1). Reaching ee’s of up to 97%, the catalytic
experiments show that the selectivity, as well as the substrate scope, of these
types of complexes are better or comparable with other catalysts based upon
monodentate ligands so far reported in literature.[8-10] This, combined with a
turnover number (TON) up to 1000 and the easy ligand synthesis and access to
structurally diverse ligands, makes the method, although slower then Noyori’s
original binap based catalyst and other bidentate ligand based catalysts, a good
candidate for possible applications in industry.
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Elucidating the structure of the complex proved, however, to be troublesome.
From 31P-NMR studies it became clear that, in the pre-catalyst, despite a Ru-
ligand ratio of 1:2, only one phosphoramidite ligand is bound per ruthenium as
an absorption was found corresponding to the free phosphoramidite ligand. We
assume that the pre-catalyst has a dimeric structure in which one
phosphoramidite ligand per ruthenium is bound. However all attempts at
obtaining further analytical data on this complex failed. From the experimental
results, however, we must conclude that in order to get good selectivity in the
hydrogenation reactions there need to be two phosphoramidite ligands per metal
center present in the reaction mixture.
Figure 1: The two best performing phosphoramidite ligands in the acetophenone and
beta-ketoester hydrogenations.
In chapter 3 we showed that the iridium catalyzed asymmetric hydrogenation of
aryl, alkyl-ketones using phosphoramidite ligands works as well. However, the
catalyst proved to be less selective compared to the ruthenium based catalyst.
Still the obtained ee’s of up to 68% are not bad for an iridium based catalyst
containing both a phosphorus type ligand and a chiral diamine. We showed that
in order to get the best results in terms of selectivity, one phosphoramidite ligand
and halve an equivalent of diamine was needed per iridium center. The
phenomenon of an iridium catalyst performing very well with only one
phosphoramidite has been observed before in the hydrogenation of a
dehydroamino acid.[12] The need for just halve an equivalent of diamine per
iridium center might point towards a dimeric type complex which is performing
the catalysis, although further research on a preformed complex will be needed
to prove this indefinitely. So far a TON of <400 is reached which is too low for
an iridium based catalyst. If further research into this catalyst also can lead to a
faster, and somewhat more selective process, this can become a good alternative
for the ruthenium based process in which the presence of a base is necessary in
order to get a good result.
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The second type of ligand that was tested in the iridium catalyzed
hydrogenations was a secondary phosphine oxide ligand. Unfortunately, its use
did not lead to very selective reactions. Also in the ruthenium catalyzed
hydrogenations, the SPO ligand did not induce selectivities that came anywhere
near the ones obtained upon the use of phosphoramidite ligands.
The complex used in the asymmetric hydrogenation of β-ketoesters as described
in chapter 4 displayed the difficulties in characterization as the complexes used
in chapter 2. Also here no clear absorption was found for a bound
phosphoramidite ligand in the 31P NMR of the precatalyst complex that was used
in the catalysis. The experimental results showed the presence of two ligands per
metal center are necessary in the reaction mixture in order to get good
selectivities. We found a metal ligand combination which was able to
hydrogenate a range of β-ketoesters with good conversions and excellent ee’s
(up to 99%). In these types of hydrogenations a phosphoramidite ligand was also
found to perform the best when two groups were present on the 3- and 3’-
positions as well as a partially saturated backbone; the 8H-3,3’-dimethylPipPhos.
This ligand proved to induce the best results in terms of selectivity, creating the
catalyst of choice for the asymmetric hydrogenation of β-ketoesters based on
monodentate ligands.[11] With a TON of up to 400 the catalyst might be
somewhat slower compared to when a bidentate ligand is used, still it might be
considered for use in industry because of its high selectivity and again easy
ligand preparation, which saves a lot of time in the production process.
Chapter 5 describes the dynamic kinetic resolution of racemic α-substituted
aldehydes via hydrogenation to the enantiopure alcohols, using the same catalyst
as developed for the asymmetric hydrogenation of aromatic ketones (Chapter 2).
Full conversions were achieved. The best enantioselectivity that was obtained
never exceeded 85%. This compares poorly with the published results that were
obtained wherein binap and SPD ligands were used. In these cases
enantioselectivities of up to 99% were obtained.[13;14] Thus, several challenges
still remain for the phosphoramidite ligands in the asymmetric hydrogenation
research.
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6.3 Outlook
The research into asymmetric hydrogenation has come a long way since the first
reports in the 1960s. Many substrate classes can be hydrogenated with good
conversions and high to excellent selectivities.[15] Also in industry, asymmetric
hydrogenations are recognized as a valuable tool for selectively introducing a
stereogenic center in a product. However, in the industrial practice the substrates
often carry many functional groups that can interfere with the hydrogenation
reaction, for instance by binding to the metal centre. Thus far, the best results
have been obtained with relatively simple substrates containing none or only non
interfering functional groups besides the olefinic double bond
In addition, some substrate classes remain for which no general asymmetric
hydrogenation method is available. Especially for compounds containing sulfur
or phosphorus functionalities no, or very limited, methods are available for fast
and selective hydrogenations.[16;17]
Figure 2: Examples of substrates and reaction types that are (still) difficult to
hydrogenate by asymmetric catalysis.
But also in the hydrogenation of aromatic compounds still some major
challenges remain. For instance the asymmetric hydrogenation of substituted
pyridines, or even more challenging the partial asymmetric hydrogenation of a
substituted benzene type substrate. The challenges in asymmetric hydrogenation
in academia these days lies with these type of substrates.
Careful screening and further understanding of the mechanisms of the
hydrogenations should lead to further insight and development of new ligands
Chapter 6
148
and methods for asymmetric hydrogenation. Monodentate ligands provide a very
valuable tool in this research as has been shown in the last ten years. Because of
their, often, easy synthesis and high structurally variability they make it easy to
screen a large number of ligands in a short amount of time increasing the
chances of finding a hit enormously compared to bidentate ligands. A second
benefit of using monodentate ligands is the fact that they make it possible to
easily use a mixture of different ligands in a mixed ligand approach, this way
increasing the amount of possible catalysts when using n ligands to n(n+1)/2.[18-
20] Another major challenge that remains in hydrogenation research is replacing
the more expensive metals like rhodium, iridium and ruthenium by the cheaper
variants like copper, nickel and iron. If efficient and selective catalysts can be
created using these types of metals, hydrogenation might become even more
interesting for use in industrial processes. Recently, interesting results have been
obtained using copper[21] and iron catalysts.[22;23]
To further exploit the use of asymmetric hydrogenation, industry should invest
in making the methods, developed by academia, applicable in their processes by
working on improving on selectivity and rate for the hydrogenation of their
specific substrates. This becomes more and more easy since a lot of ligands are
readily available and can be used in high throughput screenings. The
monodentate phosphoramidite ligands provide a major advantage in this
screening phase since beside the ligands that are commercially available the ones
that are not, are very easily synthesized, increasing the chance to find a useful hit.
Asymmetric hydrogenation can become an even more valuable tool in
asymmetric synthesis because of the fact the reactions are clean, fast, selective
and can usually be performed under relatively mild conditions. Often a catalyst
can be chosen in such a way that none of the other functionalities present in the
molecule will be affected.
Overall, asymmetric hydrogenation research has come a long way since the first
results obtained by the groups of Horner[24] and Knowles[25] but still challenges
remain in this field of research for both academia as well as industry.
Conclusions and Outlook for Further Research
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Het in de chemie zo belangrijke begrip chiraliteit komt van het Griekse woord
χειρ (“cheir”), wat hand betekent. Chirale moleculen spelen een zeer belangrijke
rol in de chemie. Een molecuul is chiraal op het moment dat het een
asymmetrisch centrum bevat en het spiegelbeeld van dit molecuul op geen
manier overlegbaar is op het origineel (zie Figuur 2). Op deze manier zijn ook
iemands handen chiraal, links en rechts zijn elkaars spiegelbeeld en niet over
elkaar heen te leggen.
Figuur 1: Voorbeeld van een chiraal molecuul met een asymmetrisch centrum (het C-
atoom met vier verschillende substituenten) en twee chirale handen.
De twee spiegelbeelden van deze chirale moleculen zijn qua eigenschappen
precies gelijk. Het enige, fysische, verschil tussen de twee is het feit dat ze
gepolariseerd licht ieder een andere kant op kunnen draaien. Een groot deel van
alle in de natuur voorkomende stoffen zijn chiraal, zoals aminozuren, DNA,
eiwitten en suikers. Doordat deze stoffen chiraal zijn is vaak het resultaat van
een interactie met een ander chiraal molecuul afhankelijk van welk enantiomeer
dat is. De consequentie is dat twee verschillende enantiomeren van dezelfde stof
een heel ander voorkomen kunnen hebben in biologische systemen. Twee
voorbeelden hiervan zijn bijvoorbeeld ketamine en limoneen. In het geval van
ketamine is het ene enantiomeer een verdovingsmiddel dat veel gebruikt wordt
door dierenartsen en het andere enantiomer een hallucinogeen. Bij limoneen is
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het de geur van de enantiomeren die volledig verschillend is. Het ene
enantiomeer heeft een typische dennengeur terwijl het andere juist naar
sinaasappelschillen ruikt.
Figuur 2: Voorbeelden van enantiomeren die verschillende biologische voorkomens
hebben. Ketamine (1.1) en limoneen (1.3).
De selectieve synthese van deze chirale moleculen is een van de belangrijkste
onderzoekstypen binnen de organische synthese.
Een van de manieren om selectief een chiraal centrum te creëren is via een
asymmetrische hydrogenering. In een asymmetrische hydrogenering reageert
een molecuul waterstof met een dubbele binding, meestal met behulp van een
katalysator welke is gebaseerd op een overgangsmetaal. Om de hydrogenering
selectief te laten verlopen zodat er voornamelijk maar een van de te vormen
enantiomeren gemaakt wordt zitten er rondom het overgangsmetaal vaak een of
meer chirale liganden.
Tot het jaar 2000 waren deze liganden eigenlijk altijd zogenaamde bidentaten,
dat wil zeggen een ligand met twee atomen die kunnen complexeren aan het
overgangsmetaal (zie Figuur 3). In dat jaar werd een einde gemaakt aan het idee
dat er bidentaat liganden nodig waren om een goede selectiviteit te kunnen
bewerkstelligen. Vrijwel tegelijkertijd publiceerden de groepen van Reetz,
Pringle en onze eigen het gebruik van monodentaat liganden in de
asymmetrische hydrogenering van C=C bindingen.
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Figuur 3: Een bidentaat ligand (binap) en de drie monodentaat liganden zoals gebruikt
door Reetz, Pringle en onze groep.
Het grote voordeel van fosforamidieten ten opzichte van de bidentaat liganden is
hun synthese. Waar de synthese van bidentaat liganden vaak veel en moeilijke
stappen bevat is een fosforamidiet in twee, makkelijke, stappen te synthetiseren
zoals te zien is in Figuur 4.
Figuur 4: Synthese van fosforamidiet liganden.
Sinds die eerste publicatie in 2000 heeft onze groep laten zien dat
fosforamidieten uitermate geschikt zijn als liganden in verschillende soorten
asymmetrische hydrogeneringen.
Het doel van het onderzoek dat in dit proefschrift is beschreven was het
ontwikkelen van methodes voor de asymmetrische hydrogenering van
carbonylen met behulp van fosforamidieten als liganden.
Figuur 5: Asymmetrische hydrogenering van acetofenonen met fosforamidiet liganden.
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In hoofdstuk 2 is het onderzoek beschreven naar een op fosforamidieten
gebaseerde ruthenium katalysator voor acetofenon achtige ketonen. We hebben
ontdekt dat een combinatie van 3,3’-dimethyl PipPhos met DACH de meest
selectieve katalysator vormt voor een reeks van acetofenonen (Figuur 5). De
pogingen om het complex te karakteriseren dat verantwoordelijk is voor de
katalyse leiden, aan de hand van 31P-NMR en massa, tot de conclusie dat het
complex dat gevormd word voor de reactie hoogstwaarschijnlijk een dimeer is
met slechts één fosforamidiet per metaalatoom. Tijdens de reactie valt dit dimeer







Figuur 6: Het SPO ligand zoals gebruikt in hoofdstuk 3.
In hoofdstuk 3 is er gekeken naar twee dingen. Ten eerste is onderzocht of een
secundair fosfine oxide (Figuur 6) gebruikt kan worden in de ruthenium of
iridium gekatalyseerde hydrogenering van acetofenon. Dit bleek wel te kunnen,
echter bleken de gevormde katalysatoren niet erg selectief te zijn. Ten tweede is
er gekeken naar de iridium gekatalyseerde hydrogenering van acetofenon met
behulp van fosforamidiet liganden. Ook hier bleek dat dit actieve katalysatoren
opleverde maar dat de selectiviteit ervan een stuk minder was ten opzichte van
de in hoofdstuk 2 gevonden katalysatoren.
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Figuur 7: Ruthenium gekatalyseerde hydrogenering van β-ketoesters met behulp van
fosforamidiet 8H-3,3’-dimethyl PipPhos.
In hoofdstuk 4 werd de aandacht verlegd naar een ander type carbonylen,
namelijk de α- en β-ketoesters. Gevonden werd dat in de hydrogenering van α-
ketoesters geen selectiviteit behaald kon worden met behulp van fosforamidiet
liganden. Voor de β-ketoesters bleek dit wel het geval. Een ruthenium complex
met twee 8H-3,3’-dimethyl PipPhos liganden bleek in staat meerdere β-
ketoesters te hydrogeneren met selectiviteiten to 99 % ee (zie figuur 7).
Figuur 8: Synthese van α-aryl aldehydes.
In hoofdstuk 5 gebruikten we de in hoofdstukken 2 en 4 gevonden katalysatoren
in de hydrogeneringen onder DKR condities van α-gesubstitueerde β-ketoesters
en α-aryl aldehydes. In de hydrogenering van de gesubstitueerde β-ketoesters
waren we helaas niet in staat om een katalysator te vinden die goede
enantiomere en diastereomere overmaat gaf.
De aldehydes die gebruikt zijn in de hydrogeneringen werden gesynthetiseerd in
twee stappen vanaf het keton zoals te zien is in Figuur 8. Eerst werd er een
Wittig methoxymethylenering gedaan en vervolgens werd het gevormde methyl
enol ether onder zure condities gehydrolyseerd tot het aldehyde in goede
opbrengsten. Voor de gesynthetiseerde aldehydes waren we in staat een
158
katalysator te vinden die tot volledige conversies leidde, echter was de
selectiviteit in geen van de gevallen hoger dan 85 %.
Concluderend kan gezegd worden dat monodentaat fosforamidiet liganden
uitermate geschikt zijn als liganden in de asymmetrische hydrogenering van




The in chemistry very important concept chirality stems from the greek word
 (“cheir”), which means hand. Chiral molecules play a most important role
in chemistry. A molecule is called chiral in the case it possesses an asymmetric
center and its mirror images are in no way superimposable onto each other. In
this way our own hands are chiral as well, they are each other’s mirror image but
in no way is it possible to position our right hand exactly over our left (see
Figure 1).
Figure 1: Example of a chiral molecule containing an asymmetric center (the C-atom
bearing four different substituents) and two chiral hands.
The two mirror images of chiral molecules have the same physical qualities. The
only difference between the two is the fact that they each rotate polarized light in
a different direction. Many of the compounds that appear in nature are chiral,
such as, DNA, amino acids, proteins and sugars. Because of he fact these
compounds are all chiral they can respond differently to interactions with other
chiral molecules depending on its enantiomer. A consequence of these different
responses to different forms of a substrate is that two enantiomers of the same
compound can have a completely different functions or appearances in nature.
Two examples of this are for instance the compound ketamine and limonene,
which are depicted in Figure 2. One of the forms of ketamine acts as an
anesthetic, which is used a lot in veterinarian medicine where the other form is
an hallucinogenic substance. For limonene it holds that both enantiomers of the
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molecule have a completely different smell. One has a typical pine like odor
whereas the other smells like orange peels.
Figure 2: Examples of enantiomers that display completely different behavior.
Ketamine (1.1) and limonene (1.3).
The selective synthesis of chiral molecules is one of the most important research
topics within the organic chemistry these days. One of the many ways to
selectively make a chiral molecule is via asymmetric hydrogenation. In an
asymmetric hydrogenation one molecule of hydrogen reacts with a double bond
which is present in the substrate molecule. This usually occurs with the help of a
transition metal based catalyst. To make sure the hydrogenation goes in a
selective manner and one of the two enantiomers of the product is formed with
high preference the transition metal is often surrounded by one or more, so
called, chiral ligands.
Until the year 2000 these chiral ligands were almost always bidentate ligands,
which means they posses two atoms that can interact with the central metal of
the catalyst. In that year three separate groups made an end to the notion that
bidentate ligands are necessary in order to get the asymmetric hydrogenations to
go with reasonable selectivities. More or less simultaneously three groups, the
ones of Pringle, Reetz and our own, published their excellent results obtained in
the asymmetric hydrogenation of a C=C double bond using two monodentate
ligands instead of one bidentate (see Figure 3).
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Figure 3: A bidentate ligand (binap) and the three monodentate ligands as used by our
group, the group of Reetz and the group of Pringle.
One of the biggest advantages of the use of monodentate ligands instead of
bidentates and especially the use of our phosphoramidites lies in their synthesis.
Where in the synthesis of bidentate ligands is often long and contains one or
more difficult steps the synthesis of a phosphoramidite ligand can be achieved in
two quick and easy steps as is depicted in Figure 4.
Figure 4: The easy two step synthesis of phosphoramidite ligands.
Since that first publication in 2000 our group has shown that phosphoramidite
ligands are very well suited as ligands in a variety of asymmetric hydrogenations.
The goal of the research described in this thesis was to develop one or several
methods in which these ligands can be used in the asymmetric hydrogenation of
carbonyls.
Figure 5: The asymmetric hydrogenations of acetophenone type substrates using a
phosporamidite ligand.
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In chapter 2 the research towards a ruthenium based catalyst, bearing
phosphoramidite ligands, for the asymmetric hydrogenation of acetophenone
type substrates is described.
We found a combination of the phosphoramidite 3,3’-dimethyl PipPhos and the
chiral diamine DACH produced the most selective catalyst for the asymmetric
hydrogenation of a range of acetophenone type substrates (See Figure 5).
Attempts to characterize the active complex, with the help of 31P-NMR and mass
spectrometry let to inconclusive results. We did conclude that the preformed
complex most likely has a dimeric structure containing one phosphoramidite and
one diamine molecule per ruthenium center. During the hydrogenation reaction
this dimer falls apart and the addition of extra equivalents of phosphoramidite






Figure 6: The SPO ligand as used in chapter 3.
In chapter 3 two separate things were investigated. First of all we examined
whether an SPO ligand (see Figure 6) could be used as a ligand in the iridium or
ruthenium catalyzed asymmetric hydrogenation of acetophenon. As it turned out
the SPO ligand could be used to get the reaction going, however, the complex
turned out not to be very selective.
Secondly we investigated the iridium catalyzed asymmetric hydrogenation of
acetophenones with phosphoramidite ligands. This proofed to work better
compared to the use of the SPO ligands but also in this case the selectivities, up
to 68% ee, came nowhere near those obtained in chapter 2.
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Figure 7: The ruthenium catalyzed asymmetric hydrogenation of β-ketoesters using 8H-
3,3’-dimethyl PipPhos as a ligand.
In chapter 4 our attention shifted towards another type of substrates, the α-, and
β-ketoesters. We found that the tested phosphoramidite ligands were not able to
induce any selectivity in the asymmetric hydrogenation of the α-ketoesters. In
the case of the β-ketoester, however, the phosphoramidite ligands proved to be
excellent performing ligands. When using the ligand 8H-3,3’-dimethyl PipPhos
we were able to achieve selectivities of up to 99% ee in the asymmetric
hydrogenation of several β-ketoesters (see figure 7).
Figure 8: Synthesis of an α-aryl aldehyde.
In chapter 5 we used the types of catalysts found in chapters 2 and 4 to perform
asymmetric hydrogenations under DKR conditions. As substrates for these type
of hydrogenations we used α-substituted β-ketoesters and α-aryl aldehydes. In
the hydrogenations of the first type of substrates we were not able to find a
catalyst which was able to induce any good ee or de in the reactions.
In the case of the aldehydes, which were easily synthesized in two steps from
their corresponding acetophenons via a Wittig reaction and subsequent
hydrolysation (see also figure 8), we were able to find a catalyst which was able
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to reduce the substrate to the corresponding alcohol with selectivities of up to
85% ee and full conversions.
In conclusion it can be stated that monodentate phosphoramidite ligands are an
excellent choice of ligands in the asymmetric hydrogenations of several carbonyl
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Rik als paranimf en contactpersoon in Groningen ben je een zeer belangrijke schakel
geweest tijdens de laatste regeldingetjes. Heel erg bedankt, niet alleen voor de
laatste maanden maar ook voor al die keren koffie, spelletjes en het kwijt kunnen
van mijn verhaal in je tussenkamer. Heel veel succes met de rest van je onderzoek
en uiteraard jouw en Ellens grote dag volgende maand.
Gijs ook jij bedankt. Niet alleen dat je mijn paranimf wil zijn maar ook voor de vele
etentjes de afgelopen jaren. Wie had gedacht dat je zo vaak uit eten kon gaan in
Zwolle en het nog steeds leuk zou vinden. Het feit dat ik er altijd weer naar uitkeek
lag toch voornamelijk aan jou. De avonden waren altijd uitermate geschikt om weer
eens lekker te relativeren en na te denken over andere dingen in het leven. Dat we
dat maar veel kunnen blijven doen, ook nadat ik gepromoveerd ben. Hetzij met zijn
tweeën, hetzij met Gerda, Hugo en Johanneke erbij.
En dan is de naam Johanneke gevallen. De laatste op het lijstje aan wie ik dank ben
verschuldigd. Dank voor het uithouden met mijn eigenwijsheid en het altijd bieden
van steun en een luisterend oor ook al ging het bij jezelf ook niet altijd van een leien
dakje. Ook jij bent er nu bijna en haalt het zeker! Waarna we nog vele jaren samen
met een goed gevoel kunnen terugkijken op de afgelopen tijd.
Met andere woorden: Bedankt iedereen!
Bart
